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Influenza B virus hemagglutinin (HA) is a major surface glycoprotein with 
frequent amino-acid substitutions. However, the roles of antibody selection in the 
amino-acid substitutions of HA were still poorly understood. An analysis was 
conducted on a total of 271 HA 1 sequences of influenza B virus strains isolated 
during 1940-2007 finding positively selected sites all located in the four major 
epitopes (120-loop, 150-loop, 160-loop and 190-helix) supporting a predominant role 
of antibody selection in HA evolution. Of particular significance is the involvement 
of the 120-loop in positive selection. Influenza B virus HA continues to evolve into 
new sub lineages, within which the four major epitopes were targeted selectively in 
positive selection. Thus, any newly emerging strains need to be placed in the context 
of their evolutionary history in order to understand and predict their epidemic 
potential. 
As key epigenetic regulators, polycomb group (PeG) proteins are responsible 
for the control of cell proliferation and differentiation as well as stem cell 
pluripotency and self-renewal. To facilitate experimental identification of PeG target 
genes, which are poorly understood, we propose a novel computational method, 
EpiPredictor, which models transcription factor interaction using a non-linear kernel. 
The resulting targets suggests that multiple transcription factor networking at the cis-
regulatory elements is critical for PeG recruitment, while high GC content and high 
conservation level are also important features of PeG target genes. 
To try to translate the EpiPredictor into human data, we performed a 
computational study utilizing 22 human genome-wide CHIP data to identify DNA 
motifs and genome features that would potentially specify PRC2 using five motif 
discovery algorithms, Jaspar known transcription binding motifs, and other whole 
genome data. We have found multiple motifs within the various subgroups of 
experimental categories that have much higher enrichment against CHIP identified 
gene promoter than among random gene promoters. Specifically, we have identified 
Low CpG content CpG Islands (LeG's) as being critical in the separation of Cancer 
cell line identified targets from Embryonic Stem cell line identified targets. 
Additionally, there are differences between human and mouse ES cell predictions 
using the same motifs and features suggesting relevant evolutionary divergence. 
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Chapter 1. Introduction 
We live in a world of data. There are over 21 million citations for biomedical 
literature in PubMed which represents about 6.3 billion words worth of information, 
and that is just from abstracts[!]. There is also the experimental data itself, already, 
the complete genome sequences from more than 180 different organisms have been 
mapped[2]; or newer whole genome expression (RNA-seq) or mapping experiments 
(CHIP-seq or Hi-C) which yield lists of potentially several thousands of genes from 
each experiment. Each set representing that which could be important in a given 
biological process or cell type. Then there is the fact that there are at least 210 
different cell types, not including cancerous or other diseased cell phenotypes, in the 
human body, each with its own unique cellular programs responsible for its 
maintenance and function[3]. All of this is just to point out that there is so much data 
already generated that it becomes critical to contextualize that which already exists 
often before new insights can be made. 
As such, bioinformatics and data analysis have become increasingly necessary 
tools as whole genome experiments have become more common. Fortunately, the 
complexity and quantity of data has been accompanied by parallel increases in 
computational power. Consequently, the modem scientist has at their disposal a host 
of sophisticated tools and techniques from which to attempt to wring useful 
information and knowledge from the vast expanse of available data[4]. 
One of the most potentially useful of the techniques is that of the Machine 
Learning Classifier (MLC). This type of analysis allows for both the mining of data 
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for previously unknown connections and the prediction of classification state based 
on said relationships. MLC's can have a large variety of forms and algorithms which 
are divided according to their purpose. These being primarily supervised, or 
unsupervised learning, which differ from each other in that supervised learning uses 
some sort of known input in order to classify a much larger unknown dataset, whereas 
unsupervised learning only attempt to classify data into its distinguishing 
components, a very common application of this being clustering programs[4]. There 
are also many other varieties that in some way combine supervised and unsupervised 
principles in their function. The importance of these techniques is that it allows data, 
which can exist in complicated multidimensional spaces, to be sorted, grouped, and 
analyzed according to the things it is most similar to according to the functional 
outcome of a given experiment, and to thus make predictions about what else should 
then share that functional outcome in a different experiment, or maybe even predict 
which data will share a completely different functional outcome from a different test 
altogether[5]. 
MLC's are so powerful in a biological context because they don't care what 
type of data that you are presenting them. The data in question could be lists of 
genes, DNA or amino acid sequences, or physical measurements; such as expression 
data or fluorescence[6]. Particular to my interests, are the applications of these 
algorithms to phylogenetic sequence organization[?], transcription factor binding 
prediction[8], and epigenetic state prediction and as such, the main goal of the 
completed work presented here is to illustrate how MLC' s can be applied in the 
analysis and subsequent insight into the biological function of two important 
biological systems: Influenza B virus hemagglutinin (HA) evolution and Polycomb 
Repressive Complex 2 (PRC2) protein targeting. 
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To do such, requires that a brief introduction into the theory behind one of the 
MLC's that will be presented, Support Vector Machine (SVM). SVM is a supervised 
learning technique which seeks to separate data in higher dimensional space through 
the use of a non-linear hyperplane. The optimization of SVM is then to determine the 
hyperplane which is able to maximize the distance of the classified training data to 
the hyperplane, and then apply that separating hyperplane to a larger set of data[9]. A 
simple 2D illustration of SVM methodology is shown in Figure 1.1. 
0 
0 
Fig. 1.1. 2D schematic illustration of hyperplane separating data. 
Let this 2D data set represent a much higher order series of data. In it a series 
of training data has been labeled by the functional classification that has been 
observed in experimental results, red for one result and blue for another. It is then 
possible to separate the data mathematically with the application of a hyperplane. 
Both H2 and H3 represent hyperplanes capable of separating the data, but H3 yields 
the maximum distance of separation and is thus established as the be classifier. 
Additionally, it possible to do this in transformed space using non-linear kernel 
functions which allows for a linear hyperplane in the transformed space to allow for 
nonlinear classification in real space. 
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Chapter 2. Influenza B Virus Hemagglutinin 
2.1 Background 
5 
Ever since the isolation of the first influenza B virus strain B/Lee/40 [10], 
influenza B virus has remained a serious health problem, contributing to the seasonal 
"flu" epidemics each year. As a major glycoprotein on the surface of influenza B 
virus, HA undergoes constant amino-acid substitutions. The HA protein of current 
circulating influenza B virus strains belongs to one of the two major phylogenetic 
lineages: BNictoria/2/87 (BNI)-like and BNamagata /16/88 (BNM)-like [11-13]. 
Over the last 68 years, a large number of amino-acid substitutions on 
influenza B virus HA were observed in field isolates, in monoclonal-antibody escape 
mutants and in egg-adapted variants [10-11, 14-22]. However, it was unclear which 
of these substitutions were the results of positive selection, and what were the roles of 
antibody selection in the molecular evolution of influenza B virus HA. In this 
context, positive selection is defined as a significant excess of amino-acid altering 
substitutions over silent substitutions in nucleotide sequences, since, if completely 
random, only 24% of nucleotide substitutions would cause changes in the encoded 
amino acids [23]. 
There was previously a sequence analysis on 49 HA1 sequences of recent 
influenza B virus isolates, which identified HA1 75, 197, and 199 (B/HongKong/8173 
HA numbering of 75, 194, and 196, respectively) to be under positive evolutionary 
selection [24]. However, since it did not separate the BNM-lineage and BNI-lineage 
strains, this study might have failed to identify those amino-acid positions that were 
6 
selected positively only in one but not the other lineage [25]. This was particularly 
problematic for the 150-loop and 160-loop (Fig.2.1), which had become specific for 
BNM-like and BNI-like strains, respectively [26-30]. Most recently, a larger-scale 
analysis that used 214 HA1 sequences of influenza B virus strains has been published 
[31]. Although it separated BNM- and BNI-lineage strains, the evolution of these 
lineages into distinct sublineages was not taken into account, which limited the 
accuracy of the positively selected sites derived therein [31]. 
PAML is a package of programs that analyze DNA and protein sequences 
using maximum likelihood [32]. Using the program CODEML in PAML, the 
nonsynonymous (amino-acid altering substitutions)/synonymous (silent substitutions) 
rate ratio (co) for each codon is calculated as an important indicator of selection 
pressure at the protein level: an co> 1 indicates positive selection [25, 32]. Bayes 
Empirical Bayes analysis then calculates the posterior probability that each site 
belongs to a particular site class. Sites with high posterior probability of belonging to 
the site class of co> 1 are inferred to be under positive selection [25, 32]. 
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Fig. 2.1. Major epitopes of influenza B virus HA. 
The trimeric HA is shown with one monomer highlighted in color: pink for HA t and yellow for HA2• 
Mutations in four regions, the 120-loop (cyan), 150-loop (green), 160-loop (blue), and 190-helix (red), 
have been found to cause antigenicity variation. The receptor-binding site (RBS) is labeled. 
In order to gain insights into the amino-acid positions on influenza B virus 
HA that are truly under positive selective pressure, here a total of 271 HAt sequences 
of influenza B virus strains isolated between 1940-2007 were analyzed. Based on the 
phylogenetic analysis, these HA 1 sequences were divided into three major groups: 
early strains (1940-1970), B/YM-like lineage (1972-2005) and BNI-like lineage 
(1975-2007). The B/YM-lineage was further divided into four sublineages, and the 
BNI lineage into two sublineages (Fig.2.2). These seven groups were analyzed by 
using CODEML in PAML version 4 [25, 32]. The identified positively selected sites 
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were located predominantly on the four major antigenic epitopes on HA 1: the 120-
loop (HA, 116-137), the 150-loop (HA1 141-150), the 160-loop (HA 1 162-167), the 
190-helix (HA 1 194-202), and their respective surrounding regions [30] (Fig.2.3), 
suggesting the important roles of antibody selection in molecular evolution of 
influenza B virus HA. 
2.2 Materials and Methods 
Phylogenetic analysis 
This study focused on the first 340 amino acid residues of mature HA1 
( 1-1020 nucleotides excluding those corresponding to the signal peptide). A total of 
271 HA1 sequences of influenza B virus strains isolated between 1940-2007 were 
used in the study. These sequences were selected to sample all the years in which 
influenza B viruses were active, and special cares were taken to avoid very similar 
stains isolated in the same regions. All the sequences were obtained from the 
Influenza Sequence Database (Los Alamos National Laboratory, Los Alamos, NM, 
USA www.flu.lanl.gov) [33]. The CLUSTAL W method [34] with the MEGALIGN 
program of DNASTAR package (www.dnastar.com) was employed for sequencing 
alignment and phylogenetic analysis. 
Analysis of selective pressure 
For this analysis, the CODEML program in PAML was used to calculate the 
codon-substitution models for heterogeneous selection pressure at amino-acid 
positions [7, 25, 32, 35]. The models used in this study were MO, M1a, M2a, M7 and 
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M8. Mla (nearly neutral) and M7 (beta) were null models that did not support ro > 
1. In contrast, the alternative models M2a (positive selection) and M8 (beta and ro), 
compared to Mla and M7 respectively, each had an additional class that allowed ro > 
1. Likelihood ratio tests (LRT) comparing M2a versus Mla and M8 versus M7 
provided test for the existence of positive selection. In LRT, twice the log likelihood 
difference, 281 = 2(1 1 -I 0 ), was compared with a X2 distribution to test whether the 
null model was to be rejected, where .e 1 and .e 0 were the log likelihood for the 
alternative model and the null model, respectively. In addition, empirical Bayes 
analysis was employed to calculate the posterior probability that each site belonged to 
a particular site class. Sites with high posterior probability of belonging to the site 
class of ro > 1 were inferred to be under positive selection. It was shown that Bayes 
Empirical Bayes, which assigned a prior to the model parameters [36], worked well 
for both small and large datasets [35]. Since some ofthe subgroups used in this study 
were small, the results from Bayes Empirical Bayes analysis were used throughout 
this study. To account for the insertions and deletions in influenza B virus HA" the 
numbering of influenza B/HongKong/8173 HA was used as a reference for all 
sequences [30]. 
------------·----
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2.3 Results 
Phylogenetic relationship of influenza B virus HA 
According to phylogenetic analysis, the 271 HA 1 sequences were divided into 
three groups: early strains isolated between 1940-1970 (1), B/YM-like lineage since 
1972 (II) and BNI-like lineage since 1975 (III). The B/YM-lineage (II) was divided 
further into four (II-i- Il-iv) sublineages (Fig.2.2), among which (II-i- Il-iii) 
sublineages had been described in a previous study [37], whilst the (II-iv) sublineage 
was described here for the first time. The BNI-lineage (III) was divided further into 
an earlier sublineage (III-i) and a more recent sublineage (III-ii) (Fig.2.2). This large-
scale phylogenetic analysis uncovered that the divergence of influenza B virus HA 
into B/YM- and BNI-lineages can be dated back to early 1970s, which is much 
earlier than previously thought [11, 13, 38-39] and agrees well with a just-published 
study [40]. 
iii 
ii 
Fig.2.2. Phylogenetic relationship of 271 HA1 sequences used in this study. 
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BNM 
iv (II) 
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For all sequences, the nucleotide sequences between 1-1020, corresponding to residues HA 1 1-340, 
were used. The phylogenetic tree was drawn using the program Megalign from DNAST AR package 
(www.dnastar.com) 
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Positive selection on influenza B virus HA 
To detect positively selected sites in HA1 sequence of influenza B virus strains 
between 1940-2007, the analysis using CODEML in PAML was performed 
individually on the seven subgroups (1, II-i - 11-iv, and 111-i - ii) (Fig.2.2). In all but 
two cases, the LRT statistics (2L\I ) for M2a versus M1a and M8 versus M7 were 
much larger than the critical value of %7% = 6.63 with degree of freedom (d.f.) set to 
1 (Tables 2.1, 2.2). Thus the LRT tests supported the existence of positive selection 
on influenza B virus HA. The sites with greater than 50% posterior probability to be 
under positive selective pressure in models M2a and M8, obtained from Bayes 
Empirical Bayes analysis [35], were listed in Table 2.3. In general, M2a identified 
fewer sites under positive selection than M8 did. Nevertheless, the sites identified in 
M2a were those of the highest posterior probability in M8 (Table 2.3). In contrast, 
those identified only in M8 but not in M2a were generally of low posterior 
probability. To be more conservative, most of our discussion was focused on the sites 
that were identified in M8 model with greater than 95% posterior probability to be 
under positive selection. This cutoff limits the false-positive rate to 5-6% or lower 
[35]. It is important to emphasize that those of high posterior probability to be under 
positive selection were not necessarily those of the highest mutation rates. Different 
from influenza A virus HA [25, 41], a much smaller number of sites on influenza B 
virus HA were subject to positive selection for antigenic drift, consistent with earlier 
studies [23, 31]. 
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Table 2.1. The values of log-likelihood ( £ ), dNids, and parameter estimates in 
the analysis of the HA1 subunit of influenza B virus strains circulating between 
1940-2007 
Model 
MO (one-ratio) 
Mia (nearly neutral) 
M2a (positive selection) 
M7 (beta) 
M8 (beta&ro) 
dNids Parameters estimates 
Early strain (I) 1940-1970 (11 strains) 
-2343.24 0.271 ro=0.271 
-2317.53 0.258 p0=0.744 (p1=0.256), roo=0.002 (ro1=l) 
-2314.85 0.297 Po=0.744, PI=0.251 (pz=0.005), Wo=0.005 (ro1=l), roz=7.990 
-2317.89 0.236 p=0.016, q=0.051 
-2315.01 0.287 Po=0.994 (J?I=0.006), p=0.017, q=0.051, ffis=7.428 
B/YM-Iineage (II-i) 1972-1984 (25 strains) 
MO (one-ratio) -2501.04 0.373 ro=0.373 
Mia (nearly neutral) -2461.96 0.262 p0=0.755 (p1=0.245), roo=0.022 (ro1=1) 
0.404 Po=0.729, PI=0.261 (pz=O.Oll), roo=0.020 (rol=l), M2a (positive selection) -2439.17 roz=ll.904 
M7 (beta) 
M8 (beta&ro) 
MO (one-ratio) 
Mia (nearly neutral) 
M2a (positive selection) 
M7 (beta) 
M8 (beta&ro) 
MO (one-ratio) 
Mia (nearly neutral) 
M2a (positive selection) 
M7 (beta) 
M8 (beta&ro) 
MO (one-ratio) 
Mia (nearly neutral) 
M2a (positive selection) 
M7 (beta) 
M8 (beta&ro) 
MO (one-ratio) 
Mia (nearly neutral) 
M2a (positive selection) 
M7 (beta) 
M8 (beta&ro) 
MO (one-ratio) 
Mia (nearly neutral) 
M2a (positive selection) 
M7 (beta) 
M8 (beta&ro) 
-2462.35 0.300 p=0.005, q=0.012 
-2439.28 0.426 p0=0.989 (p1=0.01l), p=0.017, q=0.042, ro,=12.282 
B/YM-lineage (11-ii) 1987-1996 (24 strains) 
-2032.98 0.311 ro=0.311 
-2002.40 0.188 p0=0.812 (p1=0.188), roo=O (ro1=l) 
-1995.15 0.318 Po=0.826, PI=0.136 (pz=0.038), roo=O (ro1=l ), O}z=4.779 
-2002.45 0.200 p=0.005, q=0.020 
-1995.32 0.313 p0=0.953 (p1=0.047),p=0.012, q=0.076, ro,=4.237 
B/YM-Iineage (11-iii) 1991-2002 (56 strains) 
-2211.56 0.200 ro=0.200 
-2196.38 0.168 p0=0.901 (pi=0.099), roo=0.077 (ro1=l) 
-2190.27 0.213 p0=0.936, p1=0.056 (p2=0.009), roo=0.105 (ro1=1), roz=6.802 
-2197.92 0.184 p=0.098, q=0.437 
-2190.51 0.212 p0=0.991 (p1=0.009),p=0.431, q=2.312, ro,=6.740 
B/YM-Iineage (11-iv) 1994-2005 (33 strains) 
-2144.23 0.220 ro=0.220 
-2127.98 0.211 p0=0.789 (p1=0.211), roo=O (ro1=l) 
-2127.40 0.242 Po=0.847, P1=0.022 (pz=0.131), roo=0.021 (ro1= 1), roz=l.537 
-2128.03 0.200 p=0.005, q=0.020 
-2127.40 0.242 p0=0.868 (]?1=0.132), p=0.052, q=l.023, 0>,;=1.560 
BIVI-Iineage (111-i) 1975-1993 (24 strains) 
-2530.27 0.336 ro=0.336 
-2492.37 0.251 p0=0.749 (p1=0.251), roo=O (ro1=1) 
-2477.70 0.351 p0=0.736, p1=0.254 (p2=0.010), roo=0.005 (ro1=1), roz=9.700 
-2492.81 0.222 p=0.009, q=0.029 
-2477.89 0.354 p0=0.983 (p1=0.017),p=0.016, q=0.050, ro,=7.267 
BIVI-Iineage (111-ii) 19%-2007 (98 strains) 
-2924.64 0.299 ro=0.299 
-2899.56 0.266 p0=0.805 (p1=0.195), roo=0.088 (ro1=1) 
-2887.74 0.320 Po=0.796, PI=0.199 (pz=0.005), WQ=0.094 (ro1=1), O}z=9.871 
-2899.97 0.266 p=0.156, q=0.430 
-2887.00 0.309 p0=0.994 (]?1=0.006), p=0.244, q=0.698, ro,=8.534 
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Early strain (I) (1940-1970). Among the 271 HA1 sequences analyzed in this 
study, a total of 11 sequences over a time span of 31 years belong to this group 
(Fig.2.2, Fig.S1a). To limit the uncertainties related to the relatively small number of 
samples in this group, the results from Bayes Empirical Bayes analysis were used 
throughout this study [35, 42]. In LRT tests, the values of 2dl were 5.36 for M2a 
versus M1a, and 5.76 for M8 versus M7 (Table 2.2). These values were larger than 
the critical value of .fs% = 3.84, but smaller than z~% = 6.63 with d. f. = 1 [7, 25, 32, 
35]. The M2a model suggested -0.5% sites to be under positive selection with 
0>2=7.990 (Table 2.1). Similarly, the M8 model suggested -0.6% sites to be under 
positive selection with ros=7.428. The M2a model identified a total of six sites to be 
under positive selective pressure (>50% posterior probability) (Table 2.3). The M8 
model identified 14 sites of being under positive selective pressure (>50% posterior 
probability) (Fig.2.3a). Among them, two sites were of greater than 95% posterior 
probability to be under positive selection: HA1 167 (95%)on the 160-loop and 194 
(99%) on the 190-helix. 
B/YM-like lineage (ll). A total of 138 HA1 sequences in this analysis belong to 
B/YM-like lineage. It was further divided into four sublineages, II-i (25 sequences), 
11-ii (24 sequences), 11-iii (56 sequences) and 11-iv (33 sequences) (Fig.2.2). 
Table 2.2. Likelihood ratio tests (LRT) between M2a versus Mla and MS 
versus M7 for the seven subgroups of HA1 subunit of influenza B virus strains 
circulating between 1940-2007 
LRT 
Early strain (I) 1940-1970 (11 strains) 
M2a-Mia 5.36 
M8-M7 5.76 
B/YM-Iineage (II-i) 1972-1984 (25 strains) 
M2a- Mla 44.44 
M8- M7 46.I4 
B/YM-Iineage (11-ii) 1987-1996 (24 strains) 
M2a- Mia 14.50 
M8- M7 I4.26 
B/YM-Iineage (11-iii) 1991-2002 (56 strains) 
M2a- Mla 12.22 
M8- M7 14.82 
B/YM-Iineage (11-iv) 1994-2005 (33 strains) 
M2a- Mia l.I6 
M8- M7 1.26 
BNI-Iineage (III-i) 1975-1993 (24 strains) 
M2a- Mla 29.34 
M8-M7 29.84 
BNI-Iineage (111-ii) 1996-2007 (98 strains) 
M2a- Mia 23.64 
M8-M7 25.94 
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*In LRT tests, the values of 21l £ were compared with the critical values of X2 distribution (6.63 
and 3.84 for z~% and _ts%, respectively, with d.f.=I) [7, 25, 32, 35]. Significantly larger values of 
21l £ over those of X2 distributions led to the rejection of the null models MIa and M7. 
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Fig.2.3. Sites with posterior probabilities of greater than 50 o/o to be under 
positive selection in the MS models for the seven subgroups of influenza B virus 
HA, in the order of early strain (I) (a) , B/YM-lineage (II-i- II-iv) (b-e) and BNI-lineage 
(III-i and ill-ii) (f, g). Each site is hown as a ball centered at its Cr l atom in the structure (Protein 
Data Bank code 3BT6) [30]. Sites with greater than 95% posterior probability to be under positive 
selection are shown in dark color and the rest are in light color. The structure of one monomer of HA 
is in the same orientation as the monomer shown in color in Fig.2. 1. 
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Early strain sublineage (II-i) (1972-1984). These early strains ofB/YM-
lineage spanned a period of 13 years (Fig.S1b). The 2~1 values ofM2a versus M1a 
and M8 versus M7 were much greater than X~% = 6.63 with d.f. = 1 (Tables 2.1, 2.2), 
resulting in the rejection of the null models M 1 a and M7. Both M2a and M8 models 
suggested -1.1% sites to be under strong positive selection with large ro values 
(Table 2.1). The M2a model identified a total of five sites to be under positive 
selection (>50% posterior probability) (Table 2.3), three of which were of greater 
than 95% posterior probability: HAt 129 (97%) on the 120-loop, 194 (100%) and 196 
(100%) on the 190-helix. These three sites were again with >95% posterior 
probability in the M8 model: HAt 129 (99%), 194 (100%) and 196 (100%) 
(Fig.2.3b ). 
Sublineage (11-ii) (1987-1996). The B/YM-lineage strains in this group 
covered a 10-year period (Fig.S1c). In LRT tests, the 2~1 values of M2a versus 
M1a and M8 versus M7 provided strong support for the existence of positive 
selection (Tables 2.1, 2.2). Both M2a and M8 models suggested -4% sites to be 
under positive selection with ro:::: 4 (Table 2.1). The M2a model identified two sites 
with higher than 95% posterior probability of being positively selected (Table 2.3): 
HAt 194 (99%) and 196 (97%) on the 190-helix. The M8 model identified a total of 
six sites with greater than 95% posterior probability of being positively selected 
(Table 2.3): HAt 75 (97%) and 295 (98%) on the 120-loop, 150 (96%) on the 150-
loop, 194 (100%), 196 (99%) and 227 (97%) on the 190-helix (Fig.2.3c). It is 
noteworthy that HAt 150 on the 150-loop was inferred to be under positive selection 
with very high confidence, in excellent agreement with previous conclusions that 
the 150-loop is an important epitope for B/YM-lineage [26, 29]. 
18 
Sublineage (11-iii) (1991-2002). This sublineage of B/YM-like strains 
covered a 12-year period (Fig.S1d). The LRT tests led to the rejection of the null 
models M1a and M7 (Tables 2.1, 2.2). Both M2a and M8 models suggested -0.9% 
sites to be under positive selection with ro ~ 7 (Tables 2.1, 2.2). The M2a model 
revealed three sites of being under positive selection, including HA1 194 (97%) and 
196 (99%) on the 190-helix (Table 2.3). These two sites were of99% and 100% 
posterior probability of positive selection in the M8 model (Table 2.3 and Fig.2.3d). 
Sublineage (11-iv) (1994-2005). This sublineage of B/YM-like strains 
contained some of the most recently circulating strains of B/YM-lineage (Fig.S1e). 
In sharp contrast to all other sublineages of B/YM-like strains and to all BNI-like 
strains, the LRT statistics were 2~1 =1.16 and 1.26 for M2a versus M1a and M8 
versus M7, respectively (Table 2.3), suggesting a low confidence for the existence of 
positive selection. In Bayes Empirical Bayes analysis, both M2a and M8 models 
suggested a relatively large percentage of sites ( -13%) to be under very weak positive 
selection with 0>2=1.537 and ros=l.560, respectively (Table 2.1). The M2a model 
identified a total of four positively selected sites with >50% posterior probability 
(Table 2.3). In the M8 model, a total of seven sites were identified, with only one 
site, HA1 177 (98%) on the 120-loop, with > 95% posterior probability (Table 2.3 
and Fig.2.3e). This sublineage was the only group in which HA1 194 and 196 are of 
lower than 95% probability to be under positive selection. 
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BNI-like lineage (Ill). A total of 122 HA1 sequences of influenza B virus 
strains belong to this lineage. They were grouped into two sublineages, early strains 
(111-i) containing 24 sequences and more recent strains (111-ii) containing 98 
sequences (Fig.2.2). 
Early strain sublineage (111-i) (1975-1993). These early strains of BNI-
lineage spanned a time period of 19 years and exhibited significant sequence 
differences from the recent circulating BNI-like strains (111-ii) (Fig.2.2, Fig.S1f). 
The LRT statistics supported the rejection of the null models (M1a and M7) and 
strongly supporting the presence of positive selection (Tables 2.1, 2.2). The M2a 
model suggested 1.0% sites to be under positive selection with O>z=9.700 (Table 2.1). 
Similarly, the M8 model suggested 1.7% sites to be under positive selection with 
ros=7 .267. The M2a model identified seven sites to be under positive selective 
pressure (Table 2.3), with HA1 194 (100%) and 196 (100%) on the 190-helix of 
higher than 95% posterior probability. The M8 model revealed a total of 11 
positively selected sites, among which four sites were of greater than 95% posterior 
probability. They were HA, 73 (95%) (120-loop), 167 (97%) (160-loop), 194 (100%) 
and 196 (100%) (190-helix) (Table 2.3, Fig.2.3f). It is important to note that among 
these four sites with the highest posterior probability, one site, HA1 167, is on the 
160-loop, while none is located on the 150-loop. In sharp contrast, B/YM-like (11-ii) 
sublineage, which circulated in an overlapping time period and contained the same 
number of sequences, had HA, 150 on the 150-loop to be under positive selection. 
These observations further supported earlier conclusions that the 160-loop epitope is 
specific for the BNI-lineage strains [27-28] while the 150-loop epitope is specific 
for the BNM-lineage strains [26, 29]. 
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Recent strain sublineage (111-ii) (1996-2007). The more recent isolates of 
BNI-lineage strains remained to be a single group over the time period of 12 years 
(Fig.S1g). The LRT statistics supported strongly the presence of positive selection 
(Tables 2.1, 2.2). The M2a model suggested -0.5% sites to be under positive 
selection with (lh=9.871 (Table 2.1). Similarly, the M8 model suggested -0.6% sites 
to be under positive selection with o.>s=8.534. HA1 194 had a posterior probability of 
95% and 99% to be under positive selection in M2a and M8 models, respectively, 
while HA, 196 has a 100% posterior probability in both M2a and M8 models (Table 
2.3 and Fig.2.3g). Compared to the earlier BNI-like (111-i) sublineage, one 
noticeable difference is that the 160-loop was no longer under positive selection in 
these recent strains (111-ii). Rather, positive selection was focused on the 190-helix. 
Table 2.3. Sites with higher than 50% posterior probabilities of being under 
positive selective pressure for the HA1 subunit of influenza B virus strains 
circulating between 1940-2007 
Model Positively selected sites 
Early strain (I) 1940-1970 (11 strains) 
73, 150, 167*, 194**, 196,238 
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M2a (positive selection) 
M8 (beta&ro) 73*, 121, 122, 123, 136, 146, 150*, 154*, 160, 167***, 194***, 196**, 206, 238* 
M2a (positive selection) 
M8 (beta&ro) 
M2a (positive selection) 
M8 (beta&ro) 
M2a (positive selection) 
M8 (beta&ro) 
M2a (positive selection) 
M8 (beta&ro) 
M2a (positive selection) 
M8 (beta&ro) 
M2a (positive selection) 
M8 (beta&ro) 
B/YM-lineage (II-i) 1972-1984 (25 strains) 
122, 129***, 194***, 196***, 206 
48, 122**, 129***, 137, 194***, 195, 196***, 206**, 230 
B/YM-lineage (11-ii) 1987-1996 (24 strains) 
68*, 75**, 122, 129, 150**, 194***, 196***, 200, 227**, 295** 
68**, 73, 75***, 105, 122*, 129**, 149, 150***, 194***, 196***, 199,200, 227***, 
295**** 
B/YM-lineage (11-iii) 1991-2002 (56 strains) 
176, 194***' 196*** 
75, 149, 176*, 194***, 196***, 206 
B/YM-lineage (11-iv) 1994-2005 (33 strains) 
69*, 177**, 194, 196 
56, 69**, 118, 126, 177***, 194**, 196** 
BNI-lineage (III-i) 1975-1993 (24 strains) 
73*, 116, 167**, 194***, 196***, 290,328 
68, 73***, 116**, 129, 137, 146, 167***, 194***, 196***, 290**, 328** 
BNI-lineage (III-ii) 1996-2007 (98 strains) 
194***, 196*** 
80, 121*, 129, 194***, 196*** 
Positively selected sites from Bayes Empirical Bayes analysis [35]. 
*Posterior probability of positive selective pressure is between 75-84%. 
**Posterior probability of positive selective pressure is between 85-94%. 
***Posterior probability of positive selective pressure is higher than 95%. 
2.4 Discussion 
Roles of antibody selection in the evolution of influenza B virus HA 
In previous studies, four major antigenic epitopes of influenza B virus HA, the 
120-loop, the 150-loop, the 160-loop, and the 190-helix, were identified on the 
membrane-distal domain of HA 1 [30] (Fig.2.1). Strikingly, in this study, all the 
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identified positively selected sites in the seven subgroups were located on these 
four major antigenic epitopes, supporting the important roles of antibody selection in 
the molecular evolution of influenza B virus HA. 
The 150-loop is an important epitope on HA. Antigenic properties were 
altered for influenza B virus with mutations on this loop in laboratory-selected escape 
mutants [15-16, 18, 26], field isolates [29, 43] and egg-adapted variants [44-47]. In 
more recent influenza B virus isolates, the 150-loop region appeared to be the 
neutralizing epitope specific for BNM-like strains [26, 29]. Consistent with that 
finding, HA1 150 was under positive selection with 96% posterior probability in 
BNM-like (II-ii) sublineage. 
The 160-loop is the only region in influenza B virus HA where insertions, 
deletions and single amino-acid substitutions were detected in field isolates [28, 37, 
48] and mAb-escape mutants [15-16, 18, 27, 29], as an effective way for influenza B 
virus to survive a long period of time without antigenic shifts as observed in influenza 
A virus [37]. In recent isolates, the 160-loop became specific for BNI-like lineage 
[27-28]. In agreement with this observation, HA1 167 on the 160-loop was selected 
positively in early strains (I) and in BNI-like (III-i) sublineage (Table 2.3, Fig.2.3), 
with 95% and 96% posterior probability, respectively. 
The 190-helix, which forms part of the receptor-binding site (RBS) of 
influenza B virus HA, is inarguably one of the most important epitopes. The hot spot 
is at HA1 194-196, a potential glycosylation site. Similar to influenza A virus HA 
[49-53], influenza B virus HA also utilized the addition or removal of glycosylation 
as a mechanism for antigenic drift [15-16, 30,45-46, 54-62]. In this current analysis, 
- -----
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HA1 194 and 196 were constantly identified to be under positive selective pressure, 
with greater than 99% probability in 11 out of 14 cumulative cases (combining both 
sites in seven groups), and over 85% in three other cases. HA1 227 in sublineage (!I-
ii) was another positively selected site on 190-helix with high posterior probability 
(97%) (Table 2.3, Fig.2.3). 
Perhaps one of the most important observations from this study is positive 
selection of the 120-loop region. The 120-loop epitope was defined as HA1 116-137 
and its surrounding regions [30]. In this context of this article, we refer to all sites not 
adjoining the 150-loop, 160-loop or the 190-helix epitopes as the 120-loop region due 
to spatial proximity (Fig.2.1). Although the 120-loop region appeared to be one of 
the most frequently mutated regions in field isolates [14], its role in antigenicity of 
influenza B virus HA was not recognized until most recently [30, 47, 63]. One 
possibility for such a delay in recognition is that the 120-loop is proximal to the viral 
envelope membrane, making the access by antibodies more difficult, as observed for 
influenza A virus HA [64-69]. Thus, it is very important that this current study 
provided strong evidence for positive selection of the 120-loop region, further 
supporting its significance in antigenicity of influenza B virus HA. 
Trends of positive selection on influenza B virus HA 
The early strains (I) seemed to have rather even distribution of positive 
selective pressure on all four major epitopes, although the positive selection on the 
160-loop and 190-helix appeared to be stronger and/or more prevailing (Table 2.3, 
Fig.2.3a). In contrast, the early strains of B/YM-lineage and BNI-lineage, 
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sublineages (11-ii) and (111-i) respectively, were sharply divided. HA1 150 on the 
150-loop in BNM-like (11-ii) sublineage, and HA1 167 on the 160-loop in BNI-like 
(111-i) sublineage, were inferred to be under positive selection with high posterior 
probability (Table 2.3). These observations agreed very well with earlier studies in 
which the 150-loop and 160-loop were found to be specific epitopes for the BNM-
and BNI-lineages, respectively [26-29]. However, despite large sequence 
differences, the recent BNM-like (11-iii) sublineage and BNI-like (111-ii) sublineage 
converged at focusing on the 190-helix for antigenic drift (Table 2.3 and Fig.2.3). 
Most strikingly, in the newest BNM-like (11-iv) sublineage, a large number of sites 
were found to be under rather weak positive selection, and the only positively 
selected site identified with high confidence was HA1 177 on the 120-loop. The new 
trends of positive selection among these most recent strains, in conjunction with 
results from other studies [30, 47, 63], stress the increasingly important role of the 
120-loop in antigenicity of influenza B virus HA. 
Concluding remarks 
This study reports a large-scale systematic analysis of diversifying positive 
selective pressure on HA of distinct lineages/sublineages of influenza B virus isolated 
in the past 68 years. The highlights of the results from this study are: a). The number 
of positively selected sites in influenza B virus HA were much fewer than those of 
influenza A virus HA [23]; b). Although it does not have subtypes as influenza A 
virus HA, influenza B virus HA did and continue to diverge into different 
sublineages. This was particularly true for BNM-lineage, as exemplified by the 
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newly emerging B/YM-like (11-iv) sublineage that had not been previously 
described. c). The study revealed the predominant roles of antibody selection in the 
molecular evolution of influenza B virus HA. d). Despite the differences among 
different lineages/sublineages, HA1 194 and 196 were constantly under positive 
selective pressure in all but one cases. e). The 120-loop was an important epitope 
under constant positive selection. It may play an increasingly important role in 
antigenicity in future field isolates, as evidenced in the most recent B/YM-like (11-iv) 
sublineage (Table 2.3). f). Each lineage/sublineage utilized their respective favorite 
sites in positive selection. Thus, for any newly emerging strains of influenza B virus, 
it is important to put them in the context of their evolutionary history in order to 
understand and appreciate their full epidemic potential. 
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Chapter 3. Polycomb Repressive Complex 2 
3.1 Background 
There exist two types of epigenetic modifications: DNA methylation and 
post-translational modifications on histone tails in the form of methylation (one, two, 
or three), acetylation, and ubiquitination on lysines or arginines, or phosphorylation 
of serines, leading to repressive or activated gene expression states [70-71]. 
However, the principles and mechanisms underlying epigenetic regulation remains 
one of the largest mysteries in our understanding of cellular programming. This is 
particularly true regarding how these processes are targeted toward specific genes in a 
temporal/spatial dependent manner, allowing for the complex process of cellular 
differentiation, or in the aberrant case, oncogenic transformation, to occur. Among 
them, one process under active investigation is the targeting and trimethylation of 
histone 3lysine 27 (H3K27me3) by Polycomb Repressive Complex 2 (PRC2) to 
promote a repressive state in neighboring genes[71]. 
Originally discovered in Drosophila as the regulators of homeotic (HOX) 
genes, polycomb group (PeG) proteins are well-conserved epigenetic modifiers that 
repress the expression of thousands of target genes in a given genome [72-83]. These 
target genes are essential for many fundamental, evolutionarily conserved processes 
including development, cell fate determination, proliferation, stem cell pluripotency 
and self-renewal [72, 75, 78-79, 84-87]. Mutations of PeG proteins are implicated in 
defects in stem cell fates and their abnormal levels exhibit a striking correlation with 
the severity and invasiveness of a number of cancer types including prostate cancer 
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and breast cancer [72, 75, 78-79, 84-87]. 
PeG proteins impose gene silencing through their interactions with polycomb 
response elements (PREs) that are present on the promoter regions of polycomb target 
genes [88]. This interaction is mediated by three types of multiprotein complexes, 
polycomb repressive complex 1 and 2 (PRCl and PRC2) and a recently discovered 
PhoRC that contains the DNA-binding protein Pleiohomeotic (Pho) or 
Pleiohomeotic-like (PhoL) [89] in Drosophila and Ying and Yang 1 and 2 (YYl and 
YY2) in mammals [90-92]. The known members of Drosophila PRCl include 
Polycomb (PC), Polyhomeotic (PH), Posterior sex combs (PSC) and dRing, while 
Drosophila PRC2 contains at least three core components: Enhancer of zeste (E(z)), 
Extra sex comb (Esc), and Suppressor of zeste 12 (Su(z)12) [90]. Since none of these 
PRCl and PRC2 proteins can bind to DNA directly, a hierarchical recruitment model 
has been proposed stating that DNA-binding transcription factors including Pho and 
PhoL first bind to PREs on the target genes and recruit the PRC2 complex to 
trimethylate the lysine 27 residue of histone H3 (H3K27me3) that is later bound by 
the PRCl complex for maintenance [93]. Besides Pho and PhoL, the best studied 
Drosophila transcription factors contributing to PRC2 recruitment include GAGA 
factor (GAF)/Pipsqueak (PSQ) [94-96], Zeste [97-98], Dorsal switch protein (DSP) 
[99-100], Grainyhead (Grh) [101] and Spl/KLF [102] (reviewed by Ringrose and 
Paro [ 103]). In addition, several Drosophila PREs have been identified through both 
computational and experimental analyses [104-113]. More recently, the first two 
mammalian genomic regions have been discovered to confer PeG responsiveness, one 
in the human HOXD cluster [114] and the other in the regulatory region of the 
mouse Maffi gene [80]. 
28 
Recent advances in high-throughput techniques such as chromatin 
immunoprecipitation in conjunction with microarray (ChiP-on-chip), DNA adenine 
methyltransferase identification (DamiD) and ChiP-sequencing (ChiP-seq), have 
greatly enriched our knowledge on the scale of genes regulated by PeG [72, 75-79, 
81-82, 84-87, 115-122]. However, the rather low overlaps oftarget genes identified 
in separate ChiP studies, at approximately 30% for three ChiP studies on D. 
melanogaster [75, 85-86, 103], stress the need for additional experimental and 
computational verifications of individual PeG target genes. 
This is perhaps even a more difficult problem in human biology. In order to 
shed light on mammalian PREs and their target genes, more than 22 different whole 
genome experiments across 16 different cell lines have been reported, utilizing CHIP-
CHIP or CHIP-seq techniques to map the PRC2 component proteins (Suzl2, EED, 
EZH2) or the H3K27me3 mark to specific genomic loci or to the promoter regions of 
known human genes (-24,000) [72, 76-79, 81-82, 87, 116-123] These experiments 
have yielded hundreds to thousands of genes that could be potential PRC2 targets. 
However, the identification of new bonafide PREs based on these individual CHIP 
experiments has proven difficult as CHIP experiments represent an ensemble average 
or all of the cells in the experiment and as such are subject to potential biases. They 
also fail to account for the initiation of PRC2 binding, and instead, focus mostly of 
established binding domains, which could be subject to spreading from other 
initiation loci. Finally, analysing for mammalian PRE's are made even more difficult 
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by the lack of established DNA binding proteins meaning that it is currently only 
possible to apply top-down methods of modelling, whereas in Drosophila it has been 
demonstrated that bottom up approaches are least possible, even if they are not as 
accurate as one would like. Ideally, a powerful computational method that is able to 
predict/screen, with a reasonable accuracy, PeG target genes in a given genome 
would drastically expedite experimental verification of these genes. 
In the literature, there are considerable efforts in developing computational 
methods to predict PRE sequences and to locate the genes regulated by PeG based 
upon their adjacency to PREs. For instance, Ringrose et al. investigated the 
combinatorial pattern of transcription factors known to be involved in PeG 
recruitment and assigned to each genomic region of interest a score equaling the 
weighted sum of the occurrence of every possible transcription factor pairs [113]. 
Fiedler and Rehmsmeier extended this idea and developedjPREdictor for PRE 
prediction [124]. Hauenschild and colleagues used the latest version ofjPREdictor to 
perform a genome-wide prediction on D. melanogaster and predicted 201 PREs 
together with 243 associated genes [125]. They also incorporated the aspect of 
comparative genomics and expanded their prediction to 285 PREs with 322 
associated genes. More recently, Liu et al. integrated data from a ChiP study and 
transcription factor binding analysis to predict a set of PeG target genes in mouse 
embryonic stem cells [126]. Despite these efforts, however, due to the plasticity of 
PRE sequences, developing a reliable computational PRE predictor remains a 
difficult task. For example, the overlaps between the top target genes predicted by 
--- ----------------------~ 
jPREdictor and those shown in the three recent ChiP studies in D. melanogaster 
[75, 85-86] are strikingly low (at 8%-20%). 
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We have addressed this challenge by developing a novel computational 
approach, EpiPredictor, to predict PeG target genes via the identification of PRE 
sites. With the incorporation of novel features including the use of a support vector 
machine (SVM)-based classifier, global sequence information, conservation analysis 
and comparative genomics, our approach was able to predict PeG target genes in the 
D. melanogaster genome with substantially improved accuracy. Most of the 
predicted PeG target genes are transcription factors involved in key biological 
processes such as development, neurogenesis and cell fate determination. Our results 
suggest that multiple transcription factor networking at the cis-regulatory elements is 
critical for PeG recruitment, and high GC content and high conservation level are also 
important features of PeG target genes. 
However, in order to be able to apply these same techniques into human cells 
we must first try to identify the motifs and genomic features that are the most 
applicable to human cell biology. With the wealth of new genome-wide information 
on potential PRC2 target genes, we reasoned that, by searching for conserved motifs 
amongst the genes with high CHIP signals across many different experimental 
conditions, the amount of noise can hopefully be reduced to a level at which 
meaningful results might be obtained. Since PREs in general contain multiple 
conserved motifs that attract transcription factors [113], the conserved DNA motifs 
may in turn be used as input for computational search of potential PREs that can be 
further experimentally verified. To this end, we applied multiple advanced 
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computational methods to published CHIP data and obtained a list of conserved 
DNA motifs and compared them against the known transcription factor binding 
motifs found in the Jaspar (human) [127], and select motifs from the Transfac 
(human) [128] database and motiflocalization data from Oncomine[l29]. Moreover, 
we have identified two distinct classes of motifs that are differentially enriched in 
cancer cells and in embryonic stem cells. The implications of these findings are also 
discussed. 
3.2 Materials and Methods 
3.2.1 Methods for Drosophila Modeling 
Selection of motifs 
In Drosophila, several transcription factors responsible for PeG recruitment 
have been identified, which, together with the consensus sequences of their DNA 
binding sites, are collectively referred to as motifs hereafter. We used seven motifs 
corresponding to four transcription factors, GAF (G, G 10), Pho (PS, PM, PF), 
engrailed (EN1), and Zeste (Z), all of which are known to be instrumental for PeG 
recruitment (3.1). The same motif set was also used injPREdictor [113, 125]. 
Though a few other transcription factors, e.g., DSP, Grh, Sp1/KLF, are also 
implicated in PeG recruitment in some studies, we did not include them in our current 
system because doing so did not lead to any performance improvement (data not 
shown) and also may not allow a fair comparison withjPREdictor. 
32 
Table 3.1. Motifs for transcription factors used for prediction model. 
Max 
Mutation 
Alias Motif Allowed 
G GAGAG 0 
G10 GAGAGAGAGA 1 
PS GCCAT 0 
PM NCGCCATNDNND 0 
PF GCCATHWY 0 
EN1 GSNMACGCCCC 1 
z YGAGYG 0 
Construction of the validation sets 
To validate our prediction of PeG target genes in an objective way, we used 
the gene lists reported in three recent ChiP studies in D. melanogaster, where 
Schwartz et al. [75] used ChiP-on-chip technique on S2 cultured cell line with 
antibodies to PC, E(z), PSC and H3K27me3; Tolhuis et al. [86] used DamiD 
approach on Kc cells to identify binding sites of PC, Esc, Sex combs extra (See) and 
H3K27me3; while Schuettengruber et al. [85] applied ChiP-on-chip on Drosophila 
embryos and employed antibodies to PC, PH and H3K27me3. Different choices of 
cell lines and antibodies all had an impact on the results of these experiments that 
differed from one another at varying degrees. Since our in silico PRE prediction is 
independent of any experimental conditions, we expected that a comparison of our 
results with these three well-annotated studies, which as a whole investigated a range 
of antibodies and cell types, would provide a comprehensive evaluation of our 
system. To ensure that the validation gene lists to be used were as reliable and up-to-
date as possible, we performed a post-processing procedure on the published data 
using the following stringent selection criteria. For all three validation sets, we used 
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the gene lists published by the authors as input and removed duplicates if there was 
any. We also eliminated the genes that were withdrawn in the newer release of the 
gene annotation to ensure that the validation gene sets are up-to-date. In particular, in 
processing Schwartz's data [75], we only selected the target genes with strong PeG 
binding signals to all of the four PeG proteins (PC, PSC, PH and Su(z)2) 
simultaneously as defined by the authors. As a result, we obtained three lists 
consisting of 176 (Schwartz), 225 (Tolhuis) and 215 (Schuettengruber) predicted PeG 
target genes, respectively (Appendix Table 4.1). Among them, 38 genes appeared in 
all of the three validation sets, denoted as Intersection, making the degree of overlap 
in the range of 17%-22%. 
Construction of the training set 
Our PRE classifier is a supervised learner. Therefore we needed to provide it 
with a training set of good quality. This consisted of two steps: 1) construction of a 
PRE/non-PRE sequence collection and 2) construction of the training set containing 
examples of both PRE sites (positive) and non-PRE sites (negative). 
First we constructed a sequence collection containing 12 known PRE 
sequences and 23 control (non-PRE) sequences. Among them, the 12 PRE sequences 
and 16 control sequences were the same as those used by Ringrose and colleagues 
[113, 125]. The 12 PRE sequences had solid evidence to support the existence of 
PRE site(s) within while the 16 control sequences included promoters of genes 
regulated by GAF and Zeste but not by PeG proteins [113]. To reflect the most 
recent progress in the field, we followed the same methodology used by Ringrose 
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[113] and collected seven extra control sequences (2L:131425 .. 131940; 
2L: 16715553 .. 16716125; 3R:2949268 .. 2950339; 3R:5338373 .. 5339021; 
3R:12279006 .. 12279593; 3R:12879696 .. 12880258; and 3R:19931380 .. 19931932) for 
our training set that were bound by GAP, Pho and Zeste but did not have any 
enrichment for PC, PH or H3K27me3 in a genome-wide ChiP study [85]. They were 
obtained by examining whether a given locus bound by GAP, Pho and Zeste was in 
the proximal promoter region of any gene, i.e., -1,000 to +1,000 base pairs (bps) with 
respect to the gene's transcription start site (TSS). If so, we retained the locus and the 
gene, otherwise, we discarded them. To ensure that our control sequences did interact 
with GAF, we consulted another list of GAF target genes by an independent study 
[ 130]. If the genes associated with any retained loci under investigation were not 
included in the second study, the loci were eliminated from our list. It was evident 
that, despite the addition of seven new control sequences in our study, the size of the 
sequence collection remained rather small. 
A PRE sequence containing PRE site(s) is much larger than an actual PRE 
site. Due to the limited resolution of the experimental verification process, most 
known PRE sequences included in our sequence collection spanned thousands of bps 
long whereas the core-PRE sites are usually much shorter (<200 bps) [110]. In other 
words, in addition to core PRE sites, a known PRE sequence might also contain non-
PRE sites. Thus it was prudent to identify the loci that were most likely the bona fide 
PRE sites. For this purpose, we scanned each PRE/non-PRE sequence in our 
collection with a sliding window of 200 bps that incrementally moved downstream 
with a constant step of 20 bps. For each PRE sequence, we chose the window(s) with 
35 
the highest sum of motif occurrence (calculated by the Motif Analyzer in the 
following section) as PRE sites. For every control (non-PRE) sequence, all the 
windows from scanning a control sequence were kept to ensure that the classifier was 
to be trained under very stringent condition. 
Our new system EpiPredictor 
Our system consisted of six primary components including: Motif Analyzer, 
PRE Classifier, GC Analyzer, PRE-to-gene Mapper, Conservation Level Analyzer 
and Comparative Genomics Analyzer (Fig.3.la). With the exception of PRE-to-gene 
Mapper, which was a utility module, each component rendered a unique perspective 
of investigating the genomic sequence or gene of interest. The first three units were 
centered around the prediction of PRE sites (Fig.3.1a, b) whereas the last three were 
focused on analyses at the gene level (Fig.3.1a). 
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Fig.3.1. The EpiPredictor system. A) Architecture of EpiPredictor. The modules of Motif 
Analyzer, PRE Classifier and GC Analyzer are dedicated to the prediction of PRE sites and those of 
PRE-to-gene Mapper, Conservation Level Analyzer and Comparative Genomics Analyzer are focused 
on the prediction of PeG target genes. B) Flowchart of the PRE site prediction modules of 
EpiPredictor. 
Prediction of PRE sites 
Motif Analyzer 
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We employed a sliding window of 200 bps and a step size of 20 bps to scan 
the whole genome where the DNA sequence overlapping with the window was 
captured and analyzed at any given time by the Motif Analyzer. Using a set of n 
motifs of transcription factors that were known to be involved in PeG recruitment, 
denoted by MI. M2, ••• , Mn, the Motif Analyzer constructed a profile for each window 
sequence/locus (denoted by Si) and represented it by a feature vector Fi = (/iJ, fi2, ••• , 
fin), where fii denoted the occurrence frequency of motif Mi in sequence Si. This 
feature vector was then analyzed by the pre-trained PRE classifier (below) that 
predicted whether the test window/locus was a PRE or not (Fig.3.1b). 
SVM-based PRE Classifier 
Ringrose et al. [ 113] examined the occurrence of paired motifs at the putative 
PRE sites and observed that the weighted sum of the occurrence frequencies of all 
possible motif pairs were far more effective than a linear sum up of the occurrence 
frequency of single motifs. This suggested that the pattern of transcription factor 
interactions at the PRE sites be combinatorial. In order to abstractly model the 
multifaceted interactions among transcription factors at PRE sites, we incorporated an 
SVM-based PRE classifier, which is a powerful supervised learning method for 
handling classification tasks. SVM has achieved prominent success in a spectrum of 
biological applications including gene selection [131-132], protein classification 
[133-135], cancer tissue characterization [136-137], outperforming many other classic 
machine learning techniques such as neural network, decision tree, k-nearest 
neighbor [ 138-139]. 
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There are four basic kernel functions in SVM, including linear, polynomial, 
radial basis function (RBF) and sigmoid. Given the context of PRE prediction, we 
provided a further annotation to SVM coupled with some of these kernels. For 
instance, in the case of a polynomial kernel, the parameter d corresponded to the 
degree of motif combinations, e.g. when d = 1 (equivalent to a linear kernel), only 
single motif occurrence was noted; when d = 2 (quadratic kernel), the occurrence of 
motif pairs was considered; whereas when d = 3 (cubic kernel), the occurrence of 
motif triplets was analyzed. In the case of the RBF kernel, the data was mapped to an 
infinite dimensional Hilbert space where intuitively speaking, all the motifs were 
mapped to a circlelhypersphere. Taken together, we expected the polynomial (d > 1) 
and RBF kernels to be best for modeling transcription factor interaction at the PRE 
sites. While the windows/loci classified to be non-PREs were discarded, those 
classified to be PREs had to undergo further scrutiny by GC Analyzer (below). 
GC Analyzer 
Previous studies indicated that native DNA sequence features, such as GC 
content, are associated with epigenetic modification activities such as DNA 
methylation and PeG binding [140-142]. In particular, the work of Ku et al. [76] 
suggested that CpG islands influence recruitment of PeG. Furthermore, GC-rich 
sequence elements have been shown to recruit PRC2 in mammalian embryonic stem 
cells [143] and high-CpG-density promoters are associated with highly regulated key 
developmental genes and are enriched with the H3K27me3 marks [144]. Therefore, 
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we implemented a GC Analyzer to further scrutinize the output from the PRE 
Classifier. For a sequence window/locus S; that was positively predicted by the PRE 
classifier, our GC Analyzer compared its GC ratio R; with a threshold value RT and 
discarded S; if R; <RT (Fig. 3.lb). To decide on an appropriate threshold for a region 
of 200 bps window size that we used, we examined six experimentally verified PRE 
sequences where short core PRE segments were identified [110]. The lowest GC 
ratio of these core PRE segments was 44%. We then chose this lower bound of the 
GC ratio as our threshold in order to ensure that all the verified PRE segments satisfy 
this GC ratio cut-off so that they can pass the GC Analyzer's scrutiny. We also 
compared the cut-off values of 44%, 42% or 40% on EpiPredictor, and found 44% 
yielded the best performance. Therefore, we used the 44% threshold in our 
subsequent analysis. Only the ones that passed the GC content test were considered 
as the potential PRE loci. Each locus was given a numerical score SC; by the Motif 
Analyzer that equaled the sum of motif occurrence in the sequenceS;, i.e., SC; 
Uncertainty measurement 
To characterize the probability of a predicted PRE site being the real PRE site, 
we performed a non-parametric analysis on 100 randomly generated genomes whose 
size and nucleotide distribution (A: 29%, C: 21%, T: 29%, G: 21 %) are the same as 
the D. melanogaster genome. We used our software to predict PRE sites on these 
random genomes and for a given scores we counted Os that denoted the occurrence 
of a score that is higher or equal to s. We then calculated Es, i.e., theE-value of 
scores by Os/100 and the corresponding P-value would be Es/100. 
Genome-wide prediction of PeG target genes 
PRE-to-gene Mapper 
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From our genome-wide PRE site prediction results, the PRE-to-gene Mapper 
first mapped all of the predicted PRE sites to their genomic coordinates on the 
genome. When several windows/loci adjacent to each other were all predicted to be 
PRE sites, they were all combined into a longer PRE. The Mapper then analyzed 
every locus that had a positive PRE score S, located its most adjacent gene G and 
credited G a score equaling S. If the locus was positioned closely in between two 
genes and if the second closest gene G2 was within 4,000 bps away, the Mapper 
granted G2 a score equaling S as well. 
Conservation Level Analyzer 
Due to their roles in regulating key developmental processes, PeG target genes 
were expected to be evolutionarily conserved. The Conservation Level Analyzer 
considered six Drosophila genomes that are close to D. melanogaster according to 
the phylogenetic tree [145], including D. simulans, D. sechellia, D. yakuba, D. erecta, 
D. pseudoobscura and D. ananassae. For each annotated D. melanogaster gene, it 
queried the Flybase database (www.flybase.org) to locate its orthologues in any ofthe 
six related genomes. If a gene failed to have any orthologue, it was eliminated from 
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the eligible gene list. That is, the Analyzer excluded the genes that did not have 
any orthologue in any related species from the pool of candidate genes to be 
considered as PeG targets. Eventually all the remaining genes were ranked according 
to the genes' associated PRE scores. The version of our EpiPredictor up to this point 
was termed as EpiPredictor-Basic. 
Comparative Genomics Analyzer 
We investigated the value of incorporating comparative genomics [ 146-148] 
into PeG target gene prediction. For this, we constructed a variant version of 
EpiPredictor, hereafter referred to as EpiPredictor-CG, which integrated analyses on 
three well-annotated Drosophila organisms (D. simulans, D. yakuba and D. 
pseudoobscura) that are close to D. melanogaster in the phylogenetic tree [145]. 
Our tactic in implementing EpiPredictor-CG was to construct an ensemble 
system that employed the top-ranked genes provided by our original EpiPredictor-
Basic as the base set and incorporated the information obtained from our comparative 
genomics study for rank adjustment when necessary. To be more specific, if our 
ultimate goal was to retrieve N genes that were most likely the PeG targets, we started 
our process with a gene list containing the top M genes ranked by EpiPredictor-Basic 
(M = 1.5N) and reordered the genes based upon the scores of the candidate genes' 
orthologues in different Drosophila species. 
To achieve this, we applied EpiPredictor-Basic onto each of these three 
Drosophila genomes. For each genome, all annotated genes were evaluated and 
ranked according to their predicted PRE scores. If a gene is orthologous to a D. 
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melanogaster gene, the rank of that gene was linked to its D. melanogaster gene 
orthologue. Therefore, for any D. melanogaster gene included in the top list, up to 
four ranks could be obtained, each representing the rank of the gene (or its 
orthologue) in the respective species, i.e., D. melanogaster, D. simulans, D. yakuba 
and D. pseudoobscura. A final rank was calculated by averaging all the ranks. The 
gene list was then re-sorted accordingly. 
BART -based PRE classifier 
BART (Bayesian Additive Regression Trees) is a nonparametric regression 
method that can also be used as a binary classifier. As a comparison to the SVM-
based PRE Classifier in our system, we used BART as an alternative classifier to 
evaluate whether a given locus is actually the PRE site. This was achieved by using 
the R package (BayesTree) by Hugh Chipman and Robert McCulloch. 
Computational complexity 
The primary cpmputational complexity of our EpiPredictor model came from 
the component of the SVM-based PRE classifier. During the training phase, the 
complexity of the SVM was 0( N/ + ( Ns 2 )I + NsdLl) where Ns denoted the number of 
support vectors, l denoted the number of training points and dL denoted the dimension 
of input data. During the testing phase, the complexity of the SVM was O(MNs) 
where M was 0( dL). In our experiments, Ns = 21. 
On a regular Dell desktop (Intel Duo CPU 3.00GHz, lG memory), our system 
spent 63 milliseconds in training. During the prediction phase, it took about 30 
minutes to process the entire D. melanogaster genome of 137 million bps and used 
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around 5 MB memory. Due to the integration of SVM, it was necessary to store a 
substantial amount of feature vectors onto a text file. This Input/Output process was 
responsible for the majority of the execution time. 
Importantly, our system is an automated program in which the components 
such as Motif Analyzer, SVM-based PRE Classifier and GC Analyzer were run 
sequentially requiring no human intervention after the genome sequence under study 
is input, and is readily scalable. For example, we used our software to predict the 
PeG target genes on the entire human genome and obtained complete results within 
three and a half hours on the same PC. 
In marked contrast, when we used BART as an alternative to SVM to classify 
PRE, we noticed that BART required substantial computational resources. It was 
impossible to complete the prediction of D. melanogaster genome on the same PC. 
On an Intel Xeon computer cluster which contains 134 SunFire x4150 nodes from 
Sun Microsystems, the computation took about 33 hours to complete. The average 
usage of memory is 16GB. 
Immunoprecipitation of crosslinked chromatin from D. melanogaster S2 cells 
D. melanogaster Schneider S2 cells were cultured in 1x Schneider's medium 
(Invitrogen) supplemented with 20% fetal bovine serum, 100U/ml Penicillin and 
100f,.lg/ml Streptomycin at room temperature. Cells were passaged at 1:4 ratio every 
two days to keep logarithmic growth. Crosslinking, immunoprecipitation with anti-
E(z) antibody and quantitative PCR (qPCR) were done as described previously [149]. 
In brief, 5 f,.lg anti-E(z) (Santa Cruz Biotechnology, Inc) or anti-FLAG mock antibody 
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(Sigma) were added to 4x108 crosslinked S2 cells to immunoprecipitate 
protein/DNA complexes. The antibody-protein/DNA complexes were then purified 
using 50 J.ll protein A Sephorose 4 Fast Flow Beads (GE Healthcare). DNA was 
extracted from the purified antibody-protein/DNA complexes by phenol-chlorophorm 
extraction. Purified DNA was subjected to qPCR using primer pairs designed to 
amplify DNA of -250 bps using a SYBER green detection mix (Applied 
Biosystems). All experiments were carried out in triplicates. 
3.2.2 Methods for Human Transcription Factor 
Discovery 
Computational motif discovery 
22 different CHIP data sets (Table 3.2), using the measured targets for either 
promoters (CHIP-CHIP) or specific loci (CHIP-seq), had their sequences downloaded 
from the Ensembl genome construct, and were applied to the five motif discovery 
algorithms [8, 150-152]. The top three motifs from each run were collected and 
converted into position weight matrixes (PWM) for further analysis. Each program 
was run using its default settings on a 16-node clustered CPU. To analyze the effect 
of genetic conservation, the same data sets were modified to only include sequences 
that were qualified as conserved against a 31 eutherian mammals GERP score as 
defined within the Ensembl genome browser. After shortening all sequences to only 
the conserved elements, the new data set was then reapplied to the five motif 
discovery algorithms and their top three motifs were collected and converted to 
PWMs. The output motifs for these programs were named as a combination of the 
45 
program name, which experimental data set it came from, whether it was from a 
conserved sequence alignment (as discussed below), and its motif ranking amongst 
the output of that run. 
Table 3.2. List of all 22 cell lines and antibodies used for CHIP experiments 
from literature. 
Cell line Antibody used Reference 
hES H3K27 [153] 
H1 H3K27 [81] 
H9 Suz12 [78] 
H9 EED [78] 
H9 H3K27 [78] 
H9 H3K27 [82] 
Ntera2 Suz12 [72] 
PC3 H3K27 [154] 
SW480 Suz12 [72] 
MCF7 Suz12 [72] 
TIG3 Suz12 [77] 
TIG3 H3K27 [77] 
Gastric 
adenocarcinoma H3K27 [116] 
RL Suz12 [155] 
RL H3K27 [155] 
EP156T H3K27 [87] 
EP156T H3K27 [156] 
EPTl H3K27 [156] 
EPT2 H3K27 [156] 
Dendritic cells H3K27 [157] 
Macrophages H3K27 [157] 
Monocytes H3K27 [157] 
For example, the motif 7ggm2 ie. (7)(g)(gm)(2) was generated from the data 
present in run number 7, using only conserved sequences (g) and the program (gm) 
GAD EM, and was the second highest scoring of that batch (2). Additional 
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abbreviations are: md (MDscan), ace (AlignACE), and meme (MEME). Another 
set of suffixes refers to the stringency of the CisGenome run setting while mapping 
the PWM to the genome. These are no suffix, in which default run settings are used; 
-high, where the Likelihood Ratio setting is set to 2000; -con, where the filter by 
conservation tab is checked and set to being CS>=66; and -highcon, where the two 
filters just mentioned are used together at the same time. 
Additionally a set of GAD EM and CisGenome motif discovery runs were 
taken against CpG or LeG specific regions independently of any CHIP data. These 
are labled Leg_# for LeG specific; lcg3+-# for promoters having at least 3 CpG 
islands in their promoter, while still falling in the LeG list; and cpg_edge, for using 
regions that extend +- 250 bp from defined CpG island edges, as PRC2 peaks often 
appear in these regions. Motifl-6 are a special class of GADEM run motifs which 
were computed against a composite list of promoters where the presence or absence 
of CpG islands was explored. These motifs showed to be specific to either: 
promoters with CpG islands in them(motifl and motif6), ES promoters with CpG 
islands in them(motif4), ES without CpG islands in them(motif2), orES and Cancer 
promoters regardless of CpG content(motif3 and motifS). 
Motif analysis 
The motif discovery algorithms collectively returned a list of 65 motifs to be 
analyzed. To compare each motifs' overall fitness, we mapped these motifs to a 6000 
bp window representing positions -5000 to+ 1000 with respect to the TSS was 
downloaded from the UCSC genome browser (hgl9) for all genes in the human 
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genome using CisGenome. It was to be expected that many of these motifs might 
be redundant, so to address this, if any two motifs were found to co-occupy a given 5 
bp sliding window more than 75% of the time, they were assumed to be variations of 
the same motif, and the smaller of the two motifs was eliminated from the list of 
potential motifs. This left 39 motifs. An enrichment score was then generated by 
dividing the number of genes whose promoter region contained a given motif from 
any of the data sets of interest with an appropriately sized set of randomly selected 
genes. The same methodology was carried out for PWM' s from the Jaspar or 
Transfac database of human transcription factor binding sites and applied them to 
these same gene lists. 
Model Prediction 
To determine the extent that these motifs could predict the presence or 
absence of genes found in the various CHIP experiments, a simple linear addition 
model was chosen in which the presence or absence of a motif is represented as a 
binary function and then multiplied by a binary modifier function to either allow or 
disallow a motif in the matrix from being considered. This value is then summed 
across every promoter in the genome creating a score ranging from O(has no motifs) 
to 331 (has every motif). These scores are then ranked and compared against the 
known CHIP gene lists by computing AUC scores using ROC plot. The Modifier 
function is then iteratively modified to include only the motifs that meet different 
thresholds of enrichment, until a peak is found. The highest scoring AUC score 
reported here used 155 motifs with enrichments greater than 1.2 according to the 
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NTerra2 cell line enrichments as applied to the H9suz12 CHIP list of 1040 genes. 
It was not our intention to find the best model prediction computationally possible, 
only to demonstrate that our motifs have predictive power, supporting the idea that 
DNA elements should be functionally important towards PRE discovery. 
3.3 Genome-wide Polycomb Target Gene Prediction 
in Drosophila melanogaster 
3.3.1 Results 
Empirical analysis of the SVM-based PRE classifier 
To identify the most appropriate kernel for the SVM-based PRE classifier, we 
performed an empirical analysis on the training set to gauge how well a certain kernel 
distinguished known PRE sequences. This is done using three runs of 10-fold cross 
validation so as to avoid any potential over-fitting problem. With the default 
parameters provided by LibSVM [158], the performance of all four basic kernel 
methods was analyzed by sensitivity and specificity (Table 3.3). As we expected, the 
non-linear kernels such as polynomial worked very well in distinguishing PRE 
sequences from control sequences, further confirming the advantage of modelling the 
motif interaction in a combinatorial manner. Among them, the polynomial (d=2 and 
d=3) kernels (also called the quadratic kernel and cubic kernel, respectively) 
achieved the best results in terms of specificity and sensitivity when both the average 
and standard deviation are taken into account, implicating that at the PRE sites, 
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multiple transcription factors interact with each other that as a whole serves as the 
platform for PeG recruitment. Although the cubic kernel did not significantly 
outperform the quadratic kernel, it is still the best model given all the parameters 
considered. Therefore, we used the cubic kernel on the SVM throughout our analyses. 
Table 3.3. SVM kernel evaluation 
Kernel Polynomial Polynomial 
Metric Linear (d=2) (d=3) RBF 
Sensitivity 0.80±0.05 0.80±0.05 0.82±0.03 0.60±0.05 
Specificity 0.91±0.01 0.96±0.01 0.96±0.01 0.99±0.02 
Sensitivity = TP/(TP + FN); Specificity = TN/(TN + FP), 
where TP, TN, FP, FN correspond to true positive, true negative, false positive and false negative, 
respectively. We performed three independent runs of 10-fold cross validation on the training 
collection and reported the average sensitivity/specificity and the standard deviation. 
Test of the training set 
To compare our new sequence collection with the original one used by 
Ringrose and colleagues, we ran independently EpiPredictor-Basic using the modules 
(a,b,c) on both training sets and thejPREdictor (static) on our new training set (Table 
3.4). Also included in Table 3.4 is the result ofjPREdictor (static) with Ringrose's 
training set as originally reported [125]. We found virtually no difference in 
performance when using different training sets. Therefore, we elected to use our 
training set throughout the analyses. 
Table 3.4. Comparison of our new training set (New) with Ringrose's original 
training set (Ringrose) 
Methods Training sets 
Ringrose 
EpiPredictor- New 
Basic (a,b,c) 
jPREdictor Ringrose4 
(static) New 
(a): Motif Analyzer 
(b): SVM Classifier 
(c): GC Analyzer 
Schwartz Tolhuis 
et al. 1 et al. 2 
26.14% 10.22% 
26.14% 10.22% 
21.02% 8.00% 
21.02% 8.00% 
1: Overlap with the genes predicted by Schwartz et al. [75] 
2: Overlap with the genes predicted by Tolhuis et at. [86] 
3: Overlap with the genes predicted by Schuettengruber et at. [85] 
4 : Data reported in the original publication [ 125] 
Performance evaluation of EpiPredictor components 
Schuettengruber 
et al. 3 
25.12% 
25.12% 
20.00% 
21.40% 
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We tested our classifier on the D. melanogaster genome that contains roughly 
137 million bps and 13,000 genes. Each chromosome was scanned with a sliding 
window of 200 bps and a step size of 20 bps (parameters determined by empirical 
analysis), and each window was analyzed by the Motif Analyzer component and 
represented by a seven-dimensional feature vector (each corresponding to one of the 
seven motifs we used). The performance of the system was evaluated by the 
matching ratios between our top predicted genes and those of the three validation sets 
derived from ChiP studies [75, 85-86] together with their intersection set 
(Intersection) (Table 3.6). To examine whether the performance of our system is 
sensitive to different window size and step sizes, we also varied the values of these 
parameters (Table 3.5). It is clear that with different window and step sizes, the 
performance of our system did vary slightly but the change was not very substantial. 
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Overall, the parameter setting of window size = 200, step size = 20 produced the 
best results. Therefore we used the window size of 200 bps and step size of 20 bps 
throughout. 
Table 3.5. Performance analysis of different window sizes and step sizes in Motif 
Analyzer 
Window/Step Schwartz Tolhuis Schuettengruber Intersection 
Size et al. 1 et al. 2 et al. 3 4 
W=200,S=20 26.14% 10.22% 25.12% 23.68% 
W=300,S=30 26.70% 8.89% 25.12% 21.05% 
W=400,S=40 25.57% 8.44% 24.19% 21.05% 
W=500,S=50 24.43% 8.44% 22.79% 23.68% 
W=500,S=10 25.57% 10.22% 24.19% 15.79% 
All of the percentages shown above indicate the overlap between the top 243 predicted genes using the 
EpiPredictor components (a,b,c) and those predicted by the ChiP studies. 
1: Overlap the genes predicted by Schwartz et at. [75] 
2: Overlap with the genes predicted by Tolhuis et at. [86] 
3: Overlap with the genes predicted by Schuettengruber et at. [85] 
4 : Overlap with the genes intersected by Schwartz et at., Tolhuis et at., and Schuettengruber et at. 
Our system contains multiple components. The effect of each component was 
evaluated by sequentially adding each component onto the Baseline system that used 
only the Motif Analyzer. 
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Table 3.6. Evaluation of the performance of individual EpiPredictor components 
against three genome-wide ChiP studies in D. melanogaster and their 
intersection 
Number ~piPredictor 
of Top ~omponents 
Genes 
a) 
(a, b) 
243 I (a,b,c) 
(a,b,c,d/ 
322 2 (a,b,c,d) (a,b,c,d,e/ 
(a): Motif Analyzer 
(b): SVM Classifier 
(c): GC Analyzer 
Schwartz 
et al. 5 
14.20% 'J 
22.73% 
26.14% 
27.27% 
32.39% 
35.80% 
(d): Conservation Level Analyzer 
Tolhuis Schuettengrub 
et al. 6 er et al. 7 
5.33% 12.09% 
9.78% 19.53% 
10.22% 25.12% 
10.67% 26.05% 
14.22% 30.70% 
15.11% 33.02% 
(e): Comparative Genomics Analyzer 
1
: The number of top genes retrieved from EpiPredictor-Basic analysis. 
2: The number of top genes retrieved from EpiPredictor-CG analysis. 
3: The EpiPredictor-Basic module. 
4 : The EpiPredictor-CG module. 
5: Overlap with the genes predicted by Schwartz et al. [75] 
6: Overlap with the genes predicted by Tolhuis et al. [86] 
Intersection 8 
2.63% 
23.68% 
23.68% 
26.32% 
34.21% 
44.74% 
7: Overlap with the genes predicted by Schuettengruber et al. [85] 
8
: Overlap with the genes intersected by Schwartz et al., Tolhuis et al., and Schuettengruber et al. 
9
: Suppose the validation set includes V genes. Among the top N genes predicted by our system, W 
genes matched the validation set, the overlap was represented as WIV. 
Baseline system To thoroughly evaluate the merit of each component of 
EpiPredictor, we constructed a baseline system that did not incorporate SVM or any 
other subsequent component but instead only used the Motif Analyzer that calculated 
the sum of the motif occurrence frequency. The baseline system achieved a moderate 
performance, having the matching ratios of 14.20%, 5.33%, 12.09%, 2.63%, with the 
------------------------------------- ----· 
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three validation sets and their intersection, respectively (Table 3.6). It is 
noteworthy that to perform a fair comparison withjPREdictor that reported their top 
243 genes, we also retrieved the top 243 genes from our system to obtain the 
aforementioned results. 
SVM-based PRE Classifier To estimate the merit of SVM, we then integrated 
SVM into the baseline system. The application of SVM drastically enhanced the 
performance of our system when compared to the baseline system, with matching 
ratios of22.73%, 9.78%, 19.53%, 23.68%, respectively (Table 3.6). 
GC Analyzer Subsequently we incorporated the GC Analyzer into our 
program. The prediction performance of EpiPredictor was further improved to 
26.14%, 10.22%, 25.12%, 23.68%, respectively (Table 3.6), demonstrating that the 
bona fide PeG sites tend to have relatively high GC content. 
Uncertainty measurement The non-parametric tests conducted on 100 
random genomes indicated that a PRE score of 12.7 corresponded to a P-value of 
0.0 1. In our prediction, the top 190 predicted PRE sites had a PRE score of higher 
than 12.7, with the highest score being 39.2. We also corrected the issue of multiple 
comparisons using Bonferroni correction, and found that a PRE score of 17.3 
corresponded to a P-value of 0.0001 (0.011100). In our prediction, the top 73 
predicted PRE sites had a PRE score of 17.3 or higher. Thus these top 73 predicted 
PRE sites are regarded as predictions with significant confidence, even under such a 
stringent condition. 
Conservation Level Analyzer The integration of the Conservation Level 
Analyzer slightly enhanced our system's performance to 27.27%, 10.67%, 26.05%, 
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26.32%, respectively (Table 3.6). At this point, we completed the construction of 
the basic version of our system, EpiPredictor-Basic. A complete list of the top genes 
thereby generated is provided in Appendix Table 4.2. 
It is worth mentioning that an attempt of using the base-by-base evolutionary 
conservation score compiled on D. melanogaster genome in comparison to 14 insects 
[ 148] failed to produce any improvement in the prediction performance (data not 
shown). Taken together, this suggested that the bona fide PeG target genes be most 
likely evolutionarily conserved; however, their positions might be more flexible in the 
course of evolution. 
Comparative Genomics Analyzer To evaluate the performance of 
EpiPredictor-CG, which integrated the Comparative Genomics Analyzer, we 
retrieved the top 322 predicted genes, which was the same number as generated by 
our counterpartjPREdictor (dynamic) (Appendix Table 4.3). Due to the integration 
of comparative genomics, some of the genes with lower scores were boosted up into 
the top list and yielded an improved performance of 35.80%, 15.11%, 33.02%, 
44.74%, respectively (Table 3.6), in comparison to the performance of EpiPredictor-
Basic in predicting 322 genes: 32.39%, 14.22%, 30.70%, 34.21% (Table 3.6). 
It is worth noting that the Intersection set obtained by intersecting all the three 
validation sets derived from ChiP studies [75, 85-86] did have very high matching 
ratio with our EpiPredictor-CG prediction (Table 3.6), consistent with the 
expectation that it is the highest confidence set of the target genes. 
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Performance comparison between SVM-based and BART-based PRE 
classifier 
Besides SVM, several other statistical models including BART [159] are also 
able to capture nonlinear interactions among the sequence features. For instance, Liu 
et al. used BART to predict polycomb target genes with a good performance [126]. 
Therefore we compared our system's performance using SVM-based or BART-based 
PRE classifier (Table 3.7). It is clear that the SVM-based classifier consistently 
outperformed the BART-based counterpart. 
Table 3. 7. Evaluation of the performance of our system using SVM-based PRE 
classifier vs BART -based PRE classifier 
Method EpiPredictor Components 
SVM (a, b) (a, b, c) 
BART (a, d) (a, d, c) 
(a): Motif Analyzer 
(b): SVM-based Classifier 
(c): GC Analyzer 
(d): BART-based Classifier 
Schwartz 
et al. 1 
22.73% 
26.14% 
21.59% 
22.73% 
Tolhuis Schuettgurber 
et al. 2 et al. 3 
9.78% 19.53% 
10.22% 25.12% 
8.44% 19.07% 
9.33% 22.79% 
1: Overlap between the top 243 predicted genes with the genes predicted by Schwartz eta/. [75] 
2: Overlap between the top 243 predicted genes with the genes predicted by Tolhuis eta/. [86] 
3: Overlap between the top 243 predicted genes with the genes predicted by Schuettengruber eta/. [85] 
Intersection4 
23.68% 
23.68% 
21.05% 
21.05% 
4: Overlap between the 243 predicted genes with those intersected by Schwartz et a/., Tolhuis eta/., and Schuettengruber eta/. 
Comparative analysis of EpiPredictor andjPREdictor 
We conducted a comparative analysis of EpiPredictor andjPREdictor (Table 
3.8) by using the matching ratios as well as the receiving operating characteristics 
(ROC) curve as our evaluation metrics. The former metric indicates the overall 
accuracy of prediction while the latter one depicts the trade-off between sensitivity 
and specificity, which focuses on evaluating the ranking scheme. In terms of the 
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matching ratio, EpiPredictor-Basic outperformedjPREdictor (static) by 6.25%, 
2.67%, 6.05%, 5.27%, respectively, against the three validation sets and their 
intersection set and the improvement is statistically significant (P<0.05 in one-tailed 
Students' t-test). In addition, EpiPredictor-CG surpassed the performance of 
jPREdictor (dynamic) by 7.96%, 2.67%, 10.23%, 18.42%, respectively (P<0.05). In 
terms of the area under curve (AUC) of ROC curve, EpiPredictor-Basic achieved 
comparable results withjPREdictor (static) whereas EpiPredictor-CG outperformed 
jPREdictor (dynamic) in three out of the four cases (Fig.3.2). It is worth noting that 
the AUCs of EpiPredictor-Basic, EpiPredictor-CG andjPREdictor (static) were all 
significantly larger than 0.5 (random guess) (P < 0.05) but it was not the case for 
jPREdictor (dynamic). Furthermore, using the AUCs as a measure, neither 
EpiPredictor nor jPREdictor's advanced version significantly outperformed their 
basic counterpart. 
Table 3.8. Comparison of the overlaps between the PRE genes predicted by 
EpiPredictor andjPREdictor and three genome-wide ChiP studies in D. 
melanogaster and their intersection 
Scheme Approach Schwartz Tolhuis 
et al. 1 et a/. 2 
'fipiPredictor-Basic 27.27% 10.67% 
Original 
(243 genes) jPREdictor (static/ 21.02% 8.00% 
EpiPredictor- 35.80% 15.11% Comparative CG 
Genomics jPREdictor (322 genes) (dynamic) 5 27.84% 12.44% 
: Overlap wtth the genes detected by Schwartz et al. [75] 
2: Overlap with the genes detected by Tolhuis et al. [86] 
Schuettenruber 
et al. 
26.05% 
20.00% 
33.02% 
22.79% 
3: Overlap with the genes detected by Schuettengruber et al. [85] 
intersection 
4 
26.32% 
21.05% 
44.74% 
26.32% 
4 : Overlap with the genes intersected by Schwartz et al., Tolhuis et at. Schuettengruber et al. 
5: Data reported in the original publication [125] 
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Fig.3.2. ROC curves of the PRE genes predicted by EpiPredictor andjPREdictor. 
Shown are overlaps with the genes predicted by Schwartz et al. (A), Tolhuis et al. (B), 
Schuettengruber et al. (C) and the genes intersected by all three sets (D). The AUCs on the four 
validation sets are 0.61 , 0.6 1, 0.58 and 0.60, respectively, for EpiPredictor-Basic, 0.62, 0.57, 0.62 and 
0.53, respectively, for EpiPredictor-CG, 0.64, 0.56, 0.59 and 0.67 for }PREdictor (static) , 0.56, 0.49, 
0.55 and 0.59 for }PREdictor (dynamic). 
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Fig.3.3. Gene ontology analysis of genes predicted by EpiPredictor andjPREdictor. 
Shown are the top ten gene ontology terms related to the genes predicted by: A) EpiPredictor-CG; B) 
EpiPredictor-CG but notjPREdictor (dynamic); C) }PREdictor (dynamic); D) }PREdictor (dynamic) but 
not EpiPredictor-CG; E) both EpiPredictor-CG andjPREdictor (dynamic); F) EpiPredictor-CG except 
the seven annotated genes. 
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Annotation of EpiPredictor prediction 
To reveal the major function enrichment of the genes predicted by our system 
andjPREdictor, we used the DAVID bioinformatics tool [160] to perform a gene 
ontology analysis on the genes uniquely predicted by either EpiPredictor-CG or 
jPREdictor (dynamic), as well as those predicted by both EpiPredictor-CG and 
jPREdictor (dynamic) (Fig.3.3). Most of the highly represented gene functions were 
related to the regulation of transcription, development, pattern specification, 
morphogenesis, and cell fate commitment, consistent with the expected roles of PeG 
in regulating key developmental processes of an organism [75, 77-79, 84-87]. The 
consensus genes predicted by both EpiPredictor-CG andjPREdictor (dynamic) made 
up about 28% of the top 322 genes and their corresponding gene ontology analysis 
presented good consistency with experimental studies. 
By cross-referencing existing literature, we found experimental evidence for 
seven genes, which were uniquely identified by EpiPredictor-CG and also matched at 
least one of the three ChiP studies, of their critical roles in key developmental 
processes (Table 3.9). To exemplify, the inv locus was recently found to harbor one 
PRE site which has been experimentally verified [111] and its role in regulating 
Drosophila hindgut development is well established [161]. The wg locus belongs to 
the important Wg/Wnt signal transduction pathway that directs a variety of cell fate 
decisions in developing animal embryos[162]. In Drosophila, wg alone directs a 
wide range of cell fate and patterning decisions [163]. The nub locus is involved in 
embryogenesis and neurogenesis [164-166]. The pdm21ocus is responsible for a 
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variety of cell fate decision in the Drosophila development [167]. The dac is an 
essential part of a complex that functions to induce ectopic eye development [168]. 
The Gsc mediates effective repression in Drosophila blastoderm embryos [169]. The 
tup has a key function in the development of imaginal disc [170] and is also a key 
component in early cardiogenesis [171]. Interestingly, a recent ChiP study [78] 
revealed that the human homologues of wg (WNTl), dac (DACH-1), Gsc (GSC) and 
tup (ISLl) are all targeted by PeG. In particular, WNT1 is known to be involved in 
embryogenesis and cancer development [ 172]. The functions of the genes uniquely 
identified by our system but excluding the abovementioned seven genes are shown by 
a gene ontology analysis using DAVID (Fig.3.3F). 
Table 3.9. Annotation of a set of seven genes uniquely identified by EpiPredictor 
Gene Verified Function in Drosophila Vertebrate Homolo20e 
A newly experimentally validated PRE was 
inv found to exist in the inv locus [ 111]. It is 
important for hindgut development [161] 
WNTl: predicted as 
Embryogenesis (Wingless/Wnt signaling PeG target in human 
wg [78]; involved in pathway) [163] 
embryogenesis and 
cancer [ 172] 
nub Embryogenesis, neurogenesis [ 164-166] 
pdm2 Important for a variety of cell fate decisions in development [167] 
DACH-1: predicted as 
dac Induce ectopic eye development [ 168] PeG target in human 
[78] 
Gsc groucho-dependent repression in embryo GSC: predicted as PeG [169] target in human [78] 
tup Imaginal disc development [170], key ISLl: predicted as PeG 
component in early cardiogenesis [171] tar2et in human [78] 
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To further validate our prediction, we also cross-referenced our gene list 
with the 27 PeG target genes confirmed by ChiP-qPCR in the work of Ringrose and 
colleagues [113], of which EpiPredictor-CG correctly predicted 19 genes (70%), 
exhibiting a good correlation. 
Experimental validation of EpiPredictor prediction 
In order to experimentally validate EpiPredictor prediction, ChiP-qPCR was 
used to investigate the enrichment of 15 predicted PRE sites that were randomly 
selected from the top 150 predictions (Appendix Table 4.4a) using anti-E(z) 
antibody. For positive controls we used three known PREs, bxd, iab2, and en_DM, as 
established in the literature [ 173] along with four sequences from Ringrose et al 
[113], hth, unc-4, idgf4, and cato, for which ChiP-qPCR experiments have been done 
using anti-PC antibody. Three housekeeping genes with no previous evidence as 
PRE or of polycomb related activity, hsp22, hsp26, and Pc, were selected as negative 
controls (Appendix Table 4.4b). 
The results of ChiP-qPCR showed that there are more than two-fold 
enrichments for 12 out of the 15 tested PRE sites (Fig.3.4). Among them, five 
showed enrichment greater than the average value of 5.66 for the seven positive 
controls, indicating a higher degree of confidence for their potential as PeG target 
genes. Our E(z)-ChiP derived data and Ringrose's PC data are scaled roughly to the 
same level (Table 3.10) with the exception of idgf4 which exhibited enrichment in 
our data but not in Ringrose's [113]. However, this discrepancy is not completely 
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unexpected given the fact that on the whole genome scale PC and E(z) do not 
always align well [75]. 
Table 3.10. Comparison of the qPCR data of anti-E(z) ChiP and anti-PC ChiP 
E(z) PC 
hth 6.97 11.9 
unc-4 5.42 8 
ldgf4 5.5 0.6 
cato 0.64 0.5 
By mapping the positively enriched sequences onto their closest genes, we 
found that all12 corresponding genes are of crucial importance to Drosophila 
embryonic development, since the knockout of each of these genes conferred serious 
body morphological changes. The antp and abd-A are Drosophila HOX genes [174], 
while bxd is expressed directly upstream of and is known to directly influence the 
behavior of ubx, another HOX gene [175]. Furthermore, both disco and eve regulate 
the localization or expression of HOX genes, conversely, salm and bab2 are directly 
regulated by HOX genes [176-179], while unc-4 is a homeobox-containing protein 
and a paralogue of the HOX genes with similar functions [180]. Finally, both noc 
and pnr are critical for proper eye formation [181-182], grn has importance in 
multiple organ development [183] and immune response in the midgut [184], and 
'Zjhl is essential to cell differentiation of lateral mesodermal derivative lineages and in 
neurogenesis [ 185]. The critical importance of these genes and the computational 
prediction of them being PeG target genes highlight the importance of understanding 
how sequence influences PeG binding in order to properly understand embryonic 
development in Drosophila. 
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PeG target genes are essentially free of transposons 
Transposons are mobile genetic elements that can cause mutations and change 
the amount of DNA in the genome [186]. Given their critical importance in cellular 
functions, we predicted that PeG target genes in D. melanogaster should have a 
minimal presence of transposons, generally termed as transposon-free regions 
(TFRs). We performed a whole-genome search and identified 1,400 TFRs of 
>10,000 bps in length, of which 1,232 overlapped with at least one gene's TSS. In 
the top 322 putative PeG target genes predicted by our system, 319 of them (99%) 
had TSS overlapping with one or more TFRs. Thus, as we expected, the D. 
melanogaster PeG target genes are indeed essentially free of identifiable transposon-
derived sequences. This is a novel finding in Drosophila and corroborates well with 
several recent mammalian studies that revealed strong correlations between TFRs and 
genes encoding developmental regulators [187], as well as the H3K27me3 marks 
[188]. 
64 
12 
10 
-+-> s r ~ l Q) s 
~ 
0 6 
"§ 
I::.LI 
41 
"'0 
0 
~ 
2 
0 
---
disco bxd eve salm noc lUlc-4 zfhl abd-A grn Antp pnr bab2 CGI3896 CG4774 CGI2484 
Genes 
Fig.3.4. ChiP-qPCR verification of EpiPredictor prediction. 
Shown are the enrichment of each genomic region (predicted PRE site) in S2 cell ChiP samples using 
anti-E(z) versus the use of anti-FLAG mock antibodies. The horizontal line shows an enrichment of 1 
(no enrichment). The gene symbols listed are those of the genes closest to the tested genomic region . 
For specific coordinates please refer to Appendix Table 4.4. 
3.3.2 Discussion 
Sequence ambiguity and multi-motifs in EpiPredictor 
Given the mnbiguity in the consensus sequence of motifs. our system 
considered different versions of the same motifs (for instance, PS, PM, and PF for 
Pho) as well as allowed the existence of arnbiguity codes and mutations (Table 3.1). 
In addition, by using an SVM with non-linear kernel as a PRE classifier, our program 
abstractly models how multiple motifs interact with each other at the genomic site of 
interest. These two considerations are similar to the options of position-specific 
probability matrices and multi-motifs in )PREdictor. 
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Transcription factor networking is important for PeG recruitment 
To the best of our knowledge, this is the first application of SVM to PRE 
prediction. With the integration of a non-linear kernel, our system EpiPredictor 
succeeded in modeling the spatial relationship and combinatorial interaction among 
transcription factors that are involved in PeG recruitment. This strategy offers a 
higher level of abstraction over any other approaches that use a linear function. The 
fully automated process of constructing the classifier in SVM also reduces the level 
of bias in the analysis. 
Our novel computational strategy also offers new insights into the interactions 
among transcription factors at the cis-regulatory elements in vivo. The outstanding 
performance of the non-linear kernels indicates that multiple transcription factors are 
networking at the cis-regulatory elements for efficient recruitment of PeG proteins. 
However, the details of such networking remain to be illustrated in future studies. 
High GC content and conservation level are important features of PeG target 
genes 
Among the array of perspectives that we used in EpiPredictor, SVM 
classifier, high GC content and comparative genomics allied to substantial 
performance improvements (Table 3.6). The success of integrating GC analysis 
suggested that relatively high GC content be an important feature of PeG target genes, 
consistent with previous studies that hyper-conserved CpG domains underlie 
polycomb-binding sites [142]. In addition, given their critical importance in cellular 
functions, PeG target genes are not surprisingly highly conserved in evolution. 
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PeG target genes are essential for transcription and development 
The gene ontology analysis on the genes predicted by our system revealed that 
the target genes of PeG are mainly regulators of transcription activities and are crucial 
for key developmental processes. Some genes uniquely predicted by our system are 
confirmed by several independent experimental studies to be essential for normal 
development and patterning. These observations further support the fundamental 
roles of PeG proteins in development and cellular functions. 
Prediction of TrxG target genes 
Trithorax group (TrxG) proteins methylate histone 3lysine 4 to reverse the 
repression imposed by PeG proteins [90, 189]. There exists substantial evidence that 
Trithorax response elements (TREs) and PREs co-localize. For example, several 
major TrxG proteins bind at essentially all known or presumptive PREs, suggesting 
that the regulatory platforms are switchable [90, 190]. In mouse embryonic stem 
cells, large bivalent domains were found to contain chromatin modifications 
generated by both PeG and TrxG, suggesting the co-presence of PeG and TrxG in 
developmental genes [188]. A recent genetic study on Drosophila also revealed that 
PeG repression is dynamic and that ASH1 (absent, small or homeotic discs 1), the 
histone methyltransferase belonging to the TrxG complex, is critical for the active 
state of Polycomb target genes [190]. Taken together, accumulating evidence 
suggests that the epigenetic regulations mediated by PeG and TrxG are likely to be 
closely intertwined and that the approach that accurately predicts PeG target genes 
will also shed new light on TrxG target genes. Thus it would not be surprising if the 
PeG target genes we predicted here will turn out to be TrxG target genes as well. 
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Concluding Remarks 
Despite a large number of genome-wide ChiP studies of PeG target genes [72, 
75-79, 81, 83, 85-87] recently appeared in the literature that substantially enriched 
our knowledge of the scales of PeG-mediated epigenetic modification and their roles 
in normal cellular functions and in cancer development, our mechanistic 
understanding of this process remains extremely poor. To exemplify, up to date, 
there are only two mammalian PREs [80, 114] and a dozen of Drosophila PREs [104-
113] that have been experimentally verified. In addition, there are only nine 
Drosophila transcription factors confirmed to be involved in PeG recruitment, among 
which only two have mammalian homologues [92, 191]. The extremely limited pools 
of confirmed PREs and their interacting transcription factors are the main restraints 
for the relatively mediocre performance of computational methods such as 
EpiPredictor andjPREdictor, with 20-30% matching ratios with genome-wide ChiP 
data. Although our EpiPredictor has substantially outperformedjPREdictor (by up to 
> 10% in matching ratio), we expect a much better performance if we had had more 
knowledge on PREs and their interacting transcription factors. Thus, the more 
accurate computational method such as EpiPredictor will provide a very useful tool 
for initial screening of PeG target genes from ChiP studies so as to identify the most 
likely candidates for labor-intensive experimental verifications. The enhanced 
knowledge of PREs will in tum improve the performance of these computational 
methods, and ultimately leads to a comprehensive understanding of PeG-mediated 
gene repression in normal cellular functions as well as in epigenetic dysregulation. 
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Thus, our new EpiPredictor program reported in this study represents an important 
step toward this ultimate goal in the field of epigenetics. 
3.3 Computational Discovery of DNA Motifs 
Specifying H3K27-Mediated Gene Silencing 
3.4.1 Results 
Due to the heterogeneous nature of the data, which resulted in varying 
definitions for what genes were looked at and what constituted a promoter, a 
consensus region was selected consisting of -5000 bp upstream and + 1000 bp 
downstream with respect to the transcriptional start site (TSS) of the human build 
hg19 gene annotations [192]. It was then from this promoter region that all 
subsequent computational experimentation was conducted. 
Looking across all published CHIP experiments against PRC2 and/or 
H3K27me3, a consensus list of 758 promoters (Appendix Table 4.5) that have a 
consistently high CHIP intensity score (as defined by the level of significance in the 
CHIP signals as originally reported) while still being present in at least 50% of all 
experiments. These genes, having been found to be consistently modified across a 
diverse set of developmental stages representing Embryonic Stem Cells (ESC's), a 
variety of cancer types, and normal differentiated epithelial cell lineages, thus 
represent the most comprehensive list of potential PRE's to date. 
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Computational Identification of Conserved DNA Motifs 
To identify conserved DNA motifs that are enriched in genes identified in 
CHIP experiments against PRC2 and/or H3K27me3, we ran multiple motif finding 
algorithms, MEME [193], MDscan [194], AlignACE [195] (which provided no 
unique motifs), Gadem [196], and the Gibbs Motif Sampler from CisGenome [197]. 
The results of this motif search identified more than 100 different motifs. After 
combining or removing very similar motifs, the final list contained 50 unique motifs 
(Table 3.11). 
To further characterize the identified motifs, we calculated the occurrence of 
these unique motifs across a variety of gene categories of interest including: the top 
758 identified above, as well as their specific enrichment against all of the 22 CHIP 
gene lists, separately, and against the cellular state (ESC, cancer, and differentiated) 
as an average, and also against known promoter features, such as, CpG Island 
presence, conservation, and against the expression profile of many select cancer 
tissues and cell lines using the Oncomine database[129]. 
These enrichments are then compared against various lists of between 500 to 
2000 randomly selected "background" genes not found in any CHIP data. The 
enrichment of those motifs was represented as the ratio of the occurrence among 
these lists as compared to what would be expected from a random list of the same 
size. The motifs with enrichment score of higher than 1.5 for its category are 
reported in Appendix Table 4.6. For comparison these are slightly higher than the 
enrichment scores reported in Ku et al, 2008, the highest of these being 7 gmd-
highcon, which is found in 1936 promoters and has an enrichment of 2.63 against the 
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Table 3.11. 50 unique computationally derived motifs and the programs that 
were used to create them. Shown on the left of each motif list is the number of 
genes in the genome which contain this motif within their promoter 
GAD EM Mdsean MEME CisGenome 
4167 leg3+ _gad_3 9380 17md 1086 17gmeme 3073 mat4-1eons 
2384 lcg3+_gad_8 10715 7gmd 3961 epg_edge-1-1 
12521 lcg3+_gad_6 14775 10md 203 mat_Oeons 
12191 leg3+ _gad_1 6557 14md 671 lcg3+-5 
11299 leg3+ _gad_7 19793 7gmd2 5422 epg_edge-3-2 
1896 leg3+ _gad_S 18595 1gmd2 11029 Leg_8 
11343 motif1 18894 1gmd 13791 lcg3+-4 
14911 motif2 14758 Leg_S 
12826 ctrl2 12305 leg3+-2 
11908 ctrl1 8071 epg_edge-2-1 
14927 ctrl3 15199 Leg_2 
11127 motif6 9424 Leg_3 
14585 motif4 9531 leg3+-9 
16645 10gm3 10124 leg3+-1 
16659 10gm2 12903 Leg_7 
16712 leg_ withepg_gad_3 12144 758m3 
15547 motif3 11702 leg3+-6 
17678 17ggm4 9405 leg3+-0 
18334 motifS 1011 epg_edge_3-1 
19535 lcg3+_gad_4 12728 leg3+-8-2 
7847 leg3+-8 
7419 Leg 1 
top 758 genes yielding the highest enrichment score for any single motif present in at 
least 500 promoters. 
In addition, beyond these computationally derived motifs, the motifs of known 
human and mouse transcription factors in the form of position weight matrixes 
(PWM) from Jaspar [198], and select motifs from Transfac [199] and Onomine[129] 
databases, were also analyzed to examine the potential for known transcription factor 
binding pwm's to predict PRC2 binding sites (Appendix 4.7). On average, these 
known motifs performed approximately the same as the predicted motifs; the average 
enrichment of best 10 motifs for these is 2.36 vs 2.31 for computationally derived 
motifs, with the highest of these from Jaspar being the transcription factor NFKB I 
which was found to be present in 2012 promoters in the genome and has an 
enrichment of 2.55 against the top 758 genes (Appendix 4.6e). The highest for the 
other databases is LHX3 from Oncomine with an enrichment of 2.7 against 1407 
promoters. All in all, 173 unique motifs were tested for enrichment (Appendix 
Table 4.7). 
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Fig. 3.5. Average enrichment of PRC2 marked genes in Embryonic Stem, 
Cancer, and Developed cells for high (blue) and low (red) CpG content. 
Features Beyond the Motif Level 
After initial analysis on the enrichment of the motifs, there could be seen a 
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distinct pattern between the ESC group of experiments and the Cancer group of data. 
This first revealed itself in the previously seen phenomena in which PRC2 occupancy 
has been seen to closely match with the presence of CpG Islands [200]. This is bore 
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out in our analysis as well, with the class of ESC experiments beings enriched for 
CpG Islands by 1.41. Additionally, recent research has described a bifurcation in the 
definition of CpG Islands into so called Low CpG content (LeG) and High CpG 
content (HcG) Islands [201] and have shown that HcG Islands in particular are even 
more strongly correlated with CHIP results for PRC2 in ESC's [202]. This on 
aggregate is also true, with the enrichment on all ESC CHIP results being 1. 72, an 
increase over all CpG Islands. What has not been previously observed is that while 
for promoters that have LeG Islands the a particularly low enrichment in ESC's, 0.57, 
the enrichment of this class in Cancer cells on aggregate remains very high at 1. 77, 
and is even much higher than that of the HcG class at 1.23 (Fig.3.5). This indicates 
that while in ESC's HcG Islands are marked by H3K27me3 or PRC2 and LeG Islands 
are not, in Cancer, while HcG's remain somewhat marked, (due to their overall 
importance as regulatory genes), LeG Islands drastically increase their H3K27me3 or 
PRC2 binding, with an aggregate change in enrichment greater than 3x difference 
between ESC's and cancer cells. 
This raised the interesting question of what could be special about LeG Island 
containing genes that would lead to them being so differentially modified. Gene 
Ontology analysis reveals that LeG genes are particularly enriched in the categories 
of stimulus response and extracellular processes [201], while HcG genes are enriched 
for the nuclear and transcription related processes [201]. This is also found when 
LeG's and HcG's specific to PRC2 recruitment are analyzed. This does perhaps 
indicate some mechanisms by which Cancer cells may be altering their extracellular 
response, but whether this is cause or affect is difficult to say, as it is known that 
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cancer produces a unique microenvironment to which the cells must adapt[203]. 
Consequently, to better understand how sequence could affect this, the motif 
enrichments were reanalyzed, this time to identify the motifs that showed the highest 
differential pattern between ESC regulated genes and Cancer cell regulated genes 
(Table 3.13). This shows that there are several motifs that behave in a similar 
manner as LeG with higher enrichment in Cancer cells then ESC's, while the bulk of 
the motifs show greater enrichment toward ESC's and thus could potentially indicate 
how genes might be recognized by different molecular programs. This observation 
that LeG Islands may be important in cancer is also seen looking at expression 
patterns. The database curated by Oncomine [129] has lists that they have generated 
from expression analysis across the Gene Expression Omnibus and have created their 
own series of top 10% overexpressed and underexpressed genes for given cancer or 
cell lines. Each of these lists yields approximately 500-2000 genes that are 
statistically up or down. A semi-random survey of 21 underexpressed cancer tissues 
and cell lines across Breast, Lung, Prostate, and Gastric cancers against 15 
overexpressed cancers reveal a statistically significant increase of 1.5x (.82 into 1.26; 
p-val = 2x10-6) in the enrichment of LeG Islands from overexpressed to 
underexpressed, which makes since when we factor in that the increase of LCG's in 
Cancer CHIP data reflects the potential for increased repression from PRC2. 
Additionally, this shift goes from a significantly under-enriched state to a 
significantly enriched state, suggesting a real transition is occurring. 
Motif analysis then shows that a group of motifs, which all have LeG 
enrichment and predict PRC2 occupancy (Appendix Table 4.6f) might be good 
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candidates for future experimental examination. Of particular interest among 
these, is the set of proteins which make up the Core Binding Factor Complex, 
RUNX2(osf2), PEBP, and AML2. These proteins have been shown to be oncogenes, 
which are critical in the development of the osteoblasts, but are also linked to the 
tumorgenesis of a number of different cancers [204-205], and RUNX3, another 
member of the complex (but not measured in motif analysis), additionally seems to be 
regulated by EZH2 creating the potential for feedback [206]. The binding sites for 
these proteins, particularly as taken as an intersection of different combinations of the 
three represent one of the few examples in which a factor has no significant 
enrichment against ES cell lines but which gains enrichment specific to Cancer cell 
lines (Table 3.12). 
The reverse conditions were also explored to identify which factors might be 
the most responsible for the ES cell phenotype to the exclusion of cancer or 
differentiated cells. In this case, the number of CpG islands is seen to be the highest 
predictor with promoter regions with having two CpG islands being 2.05 times and 
having three or more CpG islands 2.25 times the average enrichment in ES over 
Cancer cells. Of the motifs that would seem to predict this pattern, the highest 
differential are found amongst those motifs which have the highest enrichment for 
HCG's, particularly NRFl, NFKBl, TFAP2A, CREBl and p300, these being on 
average 1.6 times more enriched in ES cells than in Cancer cells. 
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Table 3.12. Features containing the highest differential enrichment between 
ES and Cancer cells 
Highest differential for ES Highest differential for Cancer 
Number Number 
of Feature es/can 
of genes Feature genes 
190 UCSC_CpG-3+ 2.25 3692 LCG promoters 
1325 UCSC_CpG-2+ 2.09 925 (up)C.A. vs. Norm. 
1135 UCSC_CpG-2 2.05 1420 Osf2 
64 znf354chighcon 1.79 1462 PEBP 
2012 NFKB 1-highcon 1.66 1938 758m3 high 
1466 motif6-highcon 1.63 1404 IRF (A) 
6065 nrf1-con 1.62 1139 core-binding factor 
6378 TF AP2A-highcon 1.60 1446 AML 
4194 NFKB1-con 1.60 1957 (up)C. Adenoma vs. Norm. 
3073 mat4-1cons 1.59 5147 gklfhigh 
3918 p300highcon 1.58 618 (up)D.B.C. vs. Normal 
5753 motif2-highcon 1.58 1404 Pit-1 
3831 motifl-con 1.55 1957 L. -Top 10% O.E. (Wo.) 
7611 1 Omd-highcon 1.54 68 Brachyury 
487 SMTTTTGT 1.54 1250 Nrf-1 
3484 CREB 1-highcon 1.54 1452 c-Rel 
4514 nrf1-highcon 1.53 7847 lcg3+-8 
1936 7gmd-highcon 1.53 1957 (up)G.A. vs. Norm. 
5422 cpg_edge-3-2 1.53 7419 Lcg_1 
2727 7gmd-con 1.52 136 SEF-1 
8209 motif5-highcon 1.51 1492 NF-kappaB (p65) 
1826 motifl-highcon 1.51 1481 Lmo2 complex 
5600 1 Ogmd3-highcon 1.51 1957 B.C. -Top 10% U.E. (Ad.) 
2875 motif3-highcon 1.51 1375 B.C. -Top 10% U.E. (Gy. 2) 
9095 pax4highcon 1.51 11702 lcg3+-6 
9512 10md-con 1.50 1071 Lhx3(transf) 
246 GCGNNANTTCC 1.50 8354 foxll 
5636 7 58m0highcon 1.49 12144 758m3 
5030 mp_3-1 1.49 1381 NF-kappaB (D) 
3660 motif6-con 1.49 1270 CHX10 
4285 MZF1-4-highcon 1.49 12728 lcg3+-8-2 
ES-Embryomc Stem cells; C.A.- Colon Adenocarcmoma; L.-Lymphoma; G.A.- Gastnc Intestinal Type Adenocarcmoma, B.C.-
Breast Cancer; D.B.C.- Ductal Breast Carcinoma; C.-Colon; Norm.-Normal; Wo.-Wooster; Ad.-Adai; Gy.- Gyorffy 
es/can 
0.32 
0.67 
0.68 
0.71 
0.75 
0.76 
0.78 
0.78 
0.79 
0.79 
0.80 
0.80 
0.82 
0.83 
0.84 
0.84 
0.84 
0.85 
0.85 
0.85 
0.87 
0.88 
0.89 
0.90 
0.91 
0.92 
0.92 
0.92 
0.93 
0.95 
0.95 
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Predictive Power and Evolutionary Comparison 
While motif enrichment offers tantalizing clues about how local DNA 
sequence features could potentially alter the regional chromatin state by PRC2 
mediated action, these motifs should also be able to convey some predictive power 
into either finding additional regions beyond what CHIP experiments can provide or 
offer evidence into which genes might be expected to be affected in a novel cell line. 
Drosophila PRE prediction has shown evidence that, using a set of 4-7 motifs, de 
novo PRE targets can be discovered which confer PRE behavior even while not 
standing out in CHIP [113]. Additionally, along these lines mouse PRE and motif 
prediction has shown that a similar approach may be of use in mammalian cell lines 
even while the specific mechanisms for PRC2 recruitment remain elusive. 
Unfortunately, in mammalian cell lines there are only two "true positives", one in 
mouse (KR), and one in human (HOXDll), so one has not enough data from which 
to truly train a predictive model and in affect the best you could do is try to predict 
CHIP targets. This carries with it a whole mess of assumptions and limitations that 
do not necessarily result in the most biologically relevant analysis. For this reason, 
instead of carrying out a fairly sophisticated model such as Bayesian Additive 
Regression Trees (BART) as was done by Yuan et al[207] or SVM, to classify the 
prediction potential of the motifs, instead only a simple linear summation model was 
chosen (see materials and methods). The motivation for this is that it does no good to 
create a best fit model against something to which you have less confidence in. 
However, we did wish to demonstrate that the motifs and genomic features studied 
here do possess predictive power on their own, that even with the simplest model is 
comparable to what was demonstrated in the mouse system with the more 
advanced technique. 
77 
Using Area Under the Curve (AUC) analysis against an ROC plot one is able 
to measure the predictive power of the motifs. In this type of analysis a completely 
random prediction would yield an AUC score on .5, while a perfect prediction would 
yield a score of 1.0. For this type of motif prediction we are accepting that anything 
above 0.8 can be considered a "good" predictor, and as for comparison, Yuan et al 
using mouse data on a embryonic stem cell data set using primarily TRANSF AC 
motifs, was able to create a prediction model using BART, mentioned above, with an 
AUC score of 0.8266 with all 576 motifs factored in, and a score of 0.827 when the 
model is reduced to consider only 18 factors. Using our much simpler linear 
summation model utilizing 162 features yields a wide variety of predictive scores 
against the distribution of cell lines, with ES cell lines generally yielding "good" or 
near "good" prediction power while cancer cell lines yielding only poor predictions. 
The best prediction result is from a H9 ES cell line against suz12 antibody, which 
yielded an AUC score of0.819. This number can then be increased slightly to 0.824 
if non-motif factors such as CpG content and Oncomine expression data are used. 
Most of this prediction power is retained when paired down to only 14 factors (tlxl-
nfic, rest, cpg_edge-3-2, Lcg_8, NFKB1-high, MZF1-4-con, TFAP2A-highcon, nrf1-
high, 10gm2-con, 10md-con, motif2-highcon, motif5-con, pax4highcon, and 
758m0highcon) (Fig.3.6) yields a score of 0.795, and if three more features (HCG 
promoters, UCSC_CpG-2+, and underexpressed-Colon Adenocarcinoma vs. Normal) 
are added the score becomes 0.807. This would suggest that these 17 features are the 
most important determiners of SUZ12localization in the promoter region of H9 
Embryonic Stem Cells. 
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Fig. 3.6. Position Weight Matrix depictions of the 14 motifs that yield the 
highest predictive power toward Human ES cell prediction. 
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Additionally, it is of interest to see how this prediction compares to that of 
the mouse data. Yuan et al found that their model of mouse prediction when applied 
to a lower evolutionary organism, Drosophila, resulted in generally poor prediction 
against Drosophila CHIP experiments, AUC score equals 0.667 (Fig.3.7). As such, 
all of the motifs that went into the prediction of the human H9 cell line were mapped 
to the mouse genome (mm8) with the exact same parameters in CisGenome as that 
for the human genome. Applying this data using the same prediction parameters that 
were used above onto the mouse ESC CHIP used by Yuan et al, then yields a 
decreased score of 0.77 (Fig.3.7). This score, though lower, suggests that there are 
still significant similarities between mouse and human PRC2 at the motif level, even 
while there seems to also be some evolutionary divergence as well, given the 
suggested differences between human or mouse, and drosophila prediction. To put 
into perspective 0.77 is approximately the same score as will be generated applying 
this prediction criteria to one of the H9 H3K27me3 data sets (shown in position 6 of 
Table 3.2), which is the lowest scoring of all the ES CHIP sets with this prediction 
criteria. 
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Fig. 3. 7. ROC curve for prediction results using human motif enrichment 
against human (blue), mouse (purple), and drosophila (green) compared to 
random prediction (red). 
3.4.2 Discussion 
In order to better understand PRC2 binding site predetermination across the 
human genome, we have taken a broad overview of the existing landscape of CHIP-
Chip and CHIP-seq experiments with the intention of identifying commonalities at 
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the motif and DNA feature level within the promoters of the genes identified therein. 
While we acknowledge that there are likely other genomic regions beyond just the 
gene promoters that are critical to H3K27me3 regulation, this framework is the most 
convenient toward reconciling the experimental differences in the literature with the 
need to create a consistent structure from which to apply our computational methods. 
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This approach has been to combine computationally derived motifs using 
multiple motif discovery programs with the motifs of known transcription factors 
from publically available databases, along with CpG island content and expression 
data to identify those features which best describe the CHIP experiments across a 
spectrum of different cell types which can be loosely defined as Embryonic Stem 
Cell, Cancer Cells, and Differentiated Cells. This analysis has identified several 
features that would seem to indicate that the broad genomic programs that are 
regulated by PRC2 have different properties between ES cells and Cancer cells, most 
notably in the type of CpG islands that are being modified, with LeG's showing 
significant increases in enrichment among Cancer cells lines over ES cell lines, while 
HcG enrichment is decreased. Additionally, there are several motifs that yield ES 
specific, or Can specific enrichment (Table 3.12). Also by comparing the overlap 
between each CHIP experiment with every other experiment (Table 3.13), we find 
that ES cells as a group are on average 3.25 times more enriched for the genes of 
other ES experimentally identified genes than by Cancer experimentally identified 
genes and 2.6 times more enriched over those identified in Differentiated 
experiments. We also see here that while Differentiated experiments on average are 
actually more enriched in ES experiments than Differentiated experiments, Cancer 
and ES are both more enriched amongst themselves than as compared to any other 
group (Table 3.14). 
Table 3.13. Comparison between each cell line studies with all others. Cell lines are grouped according to their class. The first section 
represents Embryonic Stem Cells, the next section represents Cancer Cells, and the third section Developed Cells. All values are presented as 
enrichments. 
#genes in exp. 2169 3676 1040 1066 1121 2687 1435 5508 1351 1293 113 548 2118 4971 9375 11088 9423 2333 1867 2412 638 1385 
Cell Line: hES HI H9 H9 H9 H9 Ntera2 PC3 SW480 MCF7 G. A. RL RL EP156T EPI56T EPTI EPT2 D.C. Mac. Mon. TIG3 TIG3 
Antibodv used: H3K27 H3K27 Suzl2 EED H3K27 H3K27 Suzl2 H3K27 Suzl2 Suzl2 H3K27 Suzl2 H3K27 H3K27 H3K27 H3K27 H3K27 H3K27 H3K27 H3K27 Suzl2 H3K27 
hES-H3K27 1.00 3.91 6.17 5.85 6.47 2.50 3.20 1.90 1.34 1.46 2.00 1.59 1.33 2.13 1.50 1.34 1.47 2.19 2.42 2.30 3.80 1.23 
Hl-H3K27 1.00 4.51 4.21 4.79 2.17 2.86 1.93 1.15 1.29 1.33 1.66 1.53 2.07 1.54 1.45 1.55 2.47 2.72 2.60 3.30 0.95 
H9-Suzl2 1.00 14.44 13.99 2.96 4.24 2.49 1.77 2.28 1.45 2.05 1.69 2.68 1.73 1.51 1.66 2.82 3.15 2.81 6.96 1.61 
H9-EED 1.00 13.75 2.79 3.35 2.37 1.43 1.75 1.59 2.04 1.67 2.53 1.67 1.47 1.59 2.43 2.76 2.45 6.54 1.40 
H9-H3K27 1.00 3.14 3.71 2.55 1.53 1.78 1.34 2.29 1.85 2.71 1.72 1.50 1.67 2.74 3.13 2.83 6.76 1.55 
H9-H3K27 1.00 1.80 1.08 0.69 0.77 1.75 1.46 1.50 1.17 1.62 1.45 1.60 2.47 2.75 2.57 2.07 1.35 
Ntera2-Suzl2 1.00 1.68 4.02 4.69 0.39 1.57 1.46 1.83 1.30 1.24 1.28 2.15 2.34 2.25 3.16 1.11 
PC3-H3K27 1.00 1.40 1.55 1.23 1.19 1.35 2.10 1.80 1.64 1.73 1.88 1.92 1.81 2.05 0.64 
SW480-Suzl2 1.00 5.75 1.67 1.47 1.64 1.49 1.07 0.98 1.08 1.23 1.35 1.08 3.36 1.18 
MCF7-Suzl2 1.00 0.44 1.23 1.87 1.59 1.13 0.98 1.09 1.57 1.65 1.41 1.39 0.65 
G.A.-H3K27 1.00 1.03 0.89 1.17 1.29 1.19 1.10 1.53 1.31 1.33 0.59 0.41 
RL-Suzl2 1.00 5.14 1.44 1.04 0.96 1.08 1.53 1.71 1.50 2.19 2.02 
RL-H3K27 1.00 1.65 1.24 1.10 1.26 1.65 1.75 1.47 1.89 2.18 
EPI56T-H3K27 1.00 2.13 1.70 1.87 1.93 2.00 1.83 2.39 0.85 
EPI56T-H3K27 1.00 1.75 1.82 1.59 1.58 1.55 1.38 1.22 
EPTI-H3K27 1.00 1.72 1.48 1.48 1.47 1.20 1.08 
EPT2-H3K27 1.00 1.56 1.58 1.53 1.39 1.24 
D.C.-H3K27 1.00 8.47 7.20 2.22 1.65 
Mac.-H3K27 1.00 7.74 2.65 1.84 
Mon.-H3K27 1.00 2.24 1.58 
TIG3-Suzl2 1.00 5.30 
TIG3-H3K27 1.00 
G.A.-Gastric Adenocarcinoma; D.C.-Dendritic Cells; Mac.-Macorphages; Mon.-Monocytes 
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Table 3.14. Similarity of PRC2 marked genes between cells of different classes 
Cell Type ES Cancer Developed 
ES 6.11 1.88 2.34 
Cancer 1.88 1.98 1.49 
Developed 2.34 1.49 2.28 
In addition to the characterization of CHIP marked promoters, we also have 
shown that a simple linear addition model of motif, at this stage in our understanding of 
PRC2 function, is probably sufficient to create working lists of likely candidate genes 
from which to explore experimentally; as this model performs approximately as well as 
the more complex BART model proposed to analyze mouse ES CHIP data. Analysis of 
this mouse data also suggests that at the multiple motif level at least, there isn't 
significant sequence difference between the genes being regulated by PRC2, as the 
application of the motifs from the human model performs only as poorly in identifying 
mouse targets as the worst of the human predictions in a similar ES cell state. The above 
evidence, combined with the fact that drosophila predictions have proven very poor at 
picking mouse targets, would suggest that the localization of PRC2 components 
throughout the genome and across a large evolutionary distance perhaps highly 
malleable, but it would suggest common features are at play in the much more closely 
related mammalian species. This does not rule out that localization could be driven at the 
macro level, perhaps toward chromatin state, rather than potentially at the motif level, 
thereby allowing PRC2 to interact with multiple classes of transcription factors as 
indicated by seeming importance of high and low CpG content CpG Island presence 
regardless of sequence. Nor does this necessarily rule out the ncRNA theory of PRC2 
recruitment, as in this case specificity is gained through complementation, and therefore 
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every binding site could have slightly different complementation characteristic which 
would not even necessarily be conserved in position across species. However, it does 
lend credence to idea that there are currently unidentified proteins, perhaps acting on the 
motifs identified above, which provide the basis for PRC2 recruitment and the resulting 
modification to gene expression mechanisms and that these proteins are probably 
conserved between humans and mice. 
Consequently, the identification of the motifs and feature focused on here will 
allow for better search criteria in the experimental identification of Bona Fide 
mammalian PRE's, and provide further insight into Cancer Biology and how the 
regulation thereof represents fundamental shifts over what would be considered "normal" 
cells, and it is through these differences that better treatments can be found. 
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Chapter 4. Appendix 
Appendix Table 4.1. Validation gene lists from Schwartz et al. 2006, Tol~uis et al. 
2006, and Schuettengruber 2009. The validation gene lists from three expenmental 
studies [75, 85-86] 
Schwartz 2006 Tolhuis 2006 
bi sob Optix Prat2 Pph13 Ucp4B nimB4 dia CG1701 
peb odd ana CG32388 Gsc eya nimB5 cad so 
Vsx2 slp1 unpg bin ds nrv2 He Pomp CG11145 
Vsx1 slp2 inv Doc3 lea CG17376 nimC1 CG31612 CG11196 
CG4766 H15 en CG5194 chinmo CG17377 Cyp28a5 tsh Hey 
mab-21 mid vg Doc2 CG15357 CG11236 ppk CG11629 CG11191 
CG9650 sens-2 Psc Doc1 CG31670 CG17375 eiB CG1421 Odc1 
ct wg Su(z)2 klu CG10908 sens-2 pburs CG1428 Odc2 
oc SoxN Sox15 CG4328 CG31668 wg Cpr35B CG2528 CG14762 
Lim1 Osi21 Oaz CG32105 CG33124 Wnt6 CG15283 CG31693 Optix 
lz salm kn toe CG15385 raw noc tio CG12769 
btd nub fus eyg dpp SoxN CG4218 CG31601 CG8635 
Sp1 ref2 grh CG32102 Iiiii CG4382 CG3473 ap pte 
disco-r pdm2 CG7229 ara CG8853 gcm2 mol CG11163 CG13743 
disco pburs rib caup drm Samuel CG15269 Or42a CG8197 
unc-4 noc otp mirr sob CG18666 esg Tsp42A ana 
OdsH esg CG9235 bru-3 odd ab CG5888 Or42b CG8083 
slgA war Rx Sox21b CG34340 CG14926 ldgf1 EcR CG11778 
zfh2 CG5888 dve D slp1 salr ldgf2 jing unpg 
ey dac retn HGTX slp2 salm ldgf3 CG15233 CG8027 
Gsc CG15167 bs CG8765 H15 Pde1c dac CG15234 wun 
chinmo ham Dll knrl CG31647 bru-2 CG4580 CG9422 wun2 
CG15357 CG10570 gsb-n kni mid nub CLIP-190 Tdc1 Mef2 
CG31670 CG17325 gsb croc CG13999 ref2 CG15167 CG15909 eve 
CG3597 tup CG16778 AP-2 CG13998 pdm2 CG10570 Tdc2 Pka-R2 
CG3609 ssp3 Kr CG14658 Vm26Ab CG15485 CG17325 Tsp42Eg psq 
CG9886 dia trh CG14659 Vm26Ac CG31856 tup Tsp42Eh CG11883 
dpp cad CG13891 opa Vm26Aa 84 ssp3 Tsp42Ei sprt 
toe ap bab1 lab psd nimA tj CG12842 CG7777 
CG8853 CG1701 bab2 Edg84A CG13992 nimB1 CG17571 Tsp42Ej qvr 
drm so vvl pb Ucp4C nimB2 CG17570 Tsp42Ek E(Pc) 
Actn3 lbl CG11920 zfh1 CG32812 fus arg inv CG17580 
Hmx I be fd96Ca Ptx1 DAAM CG8207 elav CG30034 vg 
CG18139 C15 fd96Cb Sox100B br Zasp52 CG4293 en Sans 
sr slou fkh abd-A CG3600 Poxn Appl Roc2 CG30487 
tin CG15498 Dr Abd-B csw sli vnd CG30035 Mdr49 
bap hh dmrt99B CG14909 ph-d ci CG13366 CG8234 CG3884 
zen2 Antp hth svp ph-p ey sdk lr48b CG13321 
zen grn KP78b sim CG3835 bt CG13362 CG8550 Psc 
Dfd Poxm KP78a E5 Oaz CG11231 CG13361 CG12370 Su(z)2 
Scr Or85a pros ems kn Sox102F CG5254 CG8776 CG13323 
ftz CG7443 CG3942 GATAe CG10200 CG11152 fz3 CG12442 CG13324 
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55 Ubx CG31275 CG17631 CG10202 toy tw CG12374 Prosap 
Fas1 CG31498 Glut3 pnr unc-5 sv A3-3 sea CG42287 
CG30069 CG8394 Sox15 CG17388 CG17389 
Schuettengruber2009 
abd-A CG14974 CG7443 en in aD pnr SoxN 
Abd-B CG15167 CG8765 esg ind pnt Sp1 
al CG15269 tey Ets65A inv Poxn sr 
Antp nub CG8853 eve klu Prat2 srp 
ap Hr51 CG9235 ex ex kni prd 55 
AP-2 Oaz CG9650 ey knrl pros Su(z)2 
ara CG17631 cnc eya Kr Psc sv 
Art9 ssp3 CR32730 eyg lab Ptp61 F svp 
Awh CG2014 croc fd3F laf Ptx1 tin 
B-H1 CG2052 ct fd59A I be repo tio 
B-H2 CG2543 Cyp313a3 fd96Ca lbl retn tko 
bi Sytbeta D fd96Cb Lim1 Rfx CG16778 
bin CG31275 dac fkh lz Rh5 til 
bs CG31386 Dfd tzo mab-21 rpr toe 
bsh sens-2 disco GATAe mid run toy 
btd CG31670 disco-r gl mir-276b Rx trh 
bxd CG32105 Dll grh m i r- iab-4-3p salm tsh 
cad CG32111 dmrt99B grn mirr salr tup 
caup CG32532 Doc1 gsb noc Scr twi 
CG10349 CG32713 Doc2 gsb-n oc sens Ubx 
CG10570 CG33325 Doc3 Gsc odd sim unc-4 
Fie CG33797 dpp gt OdsH Six4 unpg 
CG11023 CG33798 Dr H15 opa slou vg 
CG11629 Vsx2 drm ham Optix slp1 vnd 
CG12684 CG3835 dsx hbn Or67d slp2 wl 
CG12685 Vsx1 dve hdc OS so wg 
CG13321 CG4766 dys HGTX otp sob Wnt6 
CG13891 CG5718 E5 hh pb Sox100B zfh1 
CG13996 Hmx Edg84A hkb pdm2 Sox102F zfh2 
CG14574 CG5888 eg hth peb Sox15 
CG14659 CG6023 ems iab-4 ph-p Sox21b 
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Appendix Table 4.2. List of top 243 PeG target genes predicted by EpiPredictor-
Basic 
Gene Name 
Rbp6 pum CG6220 Pdp1 Bx grh 
hth salm tutl sm CG17839 CG32547 
Antp Ptp99A Sdc SKIP CG10793 pdm2 
CG34354 unc-13-4A disco CG10908 CG15465 rut 
Abd-B H15 shot pnr CG32720 shep 
beat-VI CG2750 htt GluCialpha Obp47a CG5778 
bi CG12540 CG33988 Cyp12e1 opa beat-Vb 
br Eip74EF CG7722 OS CG11085 CG14532 
kek5 Ubx tna mir-289 B-H1 cav 
CG34353 CG30350 chinmo OdsH CG18208 CG14298 
mbl sit CG18371 CG12637 ftz-f1 mir-280 
nAcRalpha-7E Tl dpr13 mab-21 CG32494 cbt 
bru-3 CG15464 noc CG1631 lmpl3 sog 
luna rg tlk stops ham toe 
eag disco-r sdt brk HGTX app 
abd-A CG34362 Sema-1a CG32698 CG12605 Ptr 
tou Cnx99A CG14826 ems jing cv-2 
olf413 nAcRalpha-96Aa pros CG42342 CG6734 CG2865 
CG42611 CG12484 zfh1 rib Rya-r44F E5 
ct corto Appl CG30115 eve CG9134 
tomosyn CG15025 CG9571 px CG5142 CG34393 
fas Imp tok PhKgamma Fas3 pdfr 
CG3600 Dr eya CG2444 CG6490 osa 
Vsx2 SoxN dx aPKC CG30089 
Iiiii CG33691 wg Dll CG5075 
fz2 a ret gukh wl CG6424 
ds ldgf4 nudE CG6123 CG14985 
CG14621 Dl tsh CG32204 chic 
Prat2 SK hdc Poxn CG15198 
Mur2B Optix lola nkd sens-2 
CG9650 B-H2 Ten-m CG31714 CadN 
shn CG12877 lea NFAT ETHR 
caps nAcRalpha-300 CG42339 cpo CG11997 
CG32635 Vsx1 ps Eip93F CG32111 
CG42340 unc-4 CG10349 Obp85a sa no 
CG17388 Dys CG32105 scyl CG42265 
ss CG31386 Sp1 Ids wupA 
en grn Gld2 Lar Caki 
r-cup CG17230 Rh5 Eip63E CG9308 
dpr6 CG32541 D2R ru Ca-alpha1T 
CG9059 ush scrib CG32193 CG31498 
side cad Ets98B Cda4 CG11486 
slou dpr8 Pde9 Glu-RIB CG30377 
Ten-a RunxB CG31128 lr41a CG17018 
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Appendix Table 4.3. List of top 322 PeG target genes predicted by an advanced 
version of EpiPredictor with comparative genomics integrated (EpiPredictor-CG) 
Gene Name 
Rbp6 fas SoxN GluCialpha chic 
hth Vsx2 ldgf4 osa wg 
CG34354 tutl CG17839 mab-21 shot 
mbl Cyp12e1 Vsx1 inv 01 
abd-A CG42340 ems CG17208 dpr8 
CG42611 bru-3 CG32264 CG34347 orb 
br a ret Lar lnR Dgk 
ds shn tna pros gukh 
luna lea CG31145 pnr rdx 
CG3600 ush Ca-alpha1T pum fig 
beat-VI CG13235 Ptx1 Ten-m upd3 
H15 ss CG32635 jing tomosyn 
hdc PQBP-1 sens-2 CG12551 CG15395 
olf413 noc lr94f Con CG5075 
en htt CG18478 spri aPKC 
Ubx salm apt ctp cbt 
side ftz-f1 CG9650 pdm3 CG31714 
Abd-B Antp trh Pdp1 Ser 
CG34362 zfh1 tlk Ten-a Dfd 
cpo Sdc eiB CanA-14F CG34360 
sdt eag CG10814 Tbh CG9059 
Dr grn unc-4 sog CG32547 
fz2 CadN Mmp2 rut SKIP 
Sp1 Iiiii 011 CG32541 CG32398 
CG32698 CG1499 Appl B-H2 CG30115 
CG31386 Eip63E CG32613 Mrtf drl 
SK CG15464 disco CG42339 CG13830 
px tup Ets98B opa unc-13-4A 
Glu-RIB mub Prat2 DopR2 mtt 
Sema-1a D2R RunxB CG42594 beat-lib 
CG12484 CG34353 CG14532 CG31827 Tl 
dpr6 Gld2 Obp85a nkd ps 
mir-289 cad Eip74EF CG30083 Rh5 
HGTX CG10349 dpr13 app bi 
CG6220 CG40006 fz4 pnt CG9571 
slou ct Obp47a toe CG31498 
nAcRalpha-300 shep CG18208 wl Fas3 
CG7722 sif DopR nAcRalpha-7E sm 
chinmo otp caps tsh ara 
CG32494 Caki stan Eip93F CG10126 
beat-lllc dpp corto beat-Vb eya 
CG12187 rib dac CG32521 brk 
psq caup run CG17230 Poxn 
CG9817 tok CG12540 nub CG32062 
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Pde9 Rya-r44F CG11298 
beat-VII mAcR-60C Teh1 
ham Mvl brp 
trio CG14509 scyl 
Gsc CG3650 for 
r-cup CG14521 CG14826 
Dys slo CG11486 
salr Vha16 abba 
Cpr76Bd cic lmpl3 
dx Cda4 vg 
sea OS CG6175 
CG2014 CG6123 ru 
Glut1 dpr15 kek1 
Ptr Hex-A CG5142 
brat CG30350 
Optix CG10830 
Lim1 Wnt10 
CG10908 CG14909 
CG10793 CG4669 
CG7470 CG31235 
dlg1 Takl1 
CG32111 CG13872 
ETHR CG17048 
CG33298 CG4372 
nAcRalpha-96Aa CG15465 
CG10384 wupA 
CG9134 CG32105 
NFAT CG12538 
CG14298 oc 
cenG1A CG4476 
CG33988 Hip14 
beat-lla CG16716 
lbl pdm2 
CG31337 fj 
KrT95D CG4168 
CG12835 CGBBBB 
CG18371 CG11085 
bab1 CG1986 
CG18482 Mur2B 
stops elk 
CG13972 eyg 
prod Vha16-3 
ade5 CG9308 
CG15630 CG15233 
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Appendix Table 4.4. Genomic coordinates and genes, along with the primers, used 
for qPCR. 
A. 15 selected genomic regions from prediction 
Closest Gene Genomic Coordinates Prediction Rank Primers (top-foreward) 
Antp 3R:2826281 .. 2826940 18 GGCATCCAAACATCCACTTG 
TTATGAGTGTGCGTCTGTGG 
disco X:16110941..16111700 9 GTTTCGTTGGGTTGACACATG 
CATTGCCATTTCACTCTCGTTG 
eve 2R:5865941..5866860 15 CGGCATAATATTAAGACTTCA 
TCCCACTATATATTTGTATGTATG 
unc-4 X:17662101 .. 17662800 10 GGCTGATCGAAATTGAAACGG 
AGCGAGGAAACCCAGAAAAG 
ubx 3R:12589661..12590180 25 CTGTATCTCGCTCTTACGCAC 
CAAAACACGAATACAAGCCCG 
salm 2L: 11445481..11446280 2 CACTATCACTCAGCCAACCC 
ATCCCGAGGCAAAAGTAGAAG 
noc 2L: 14490381..14491000 8 TTACAGGAAGCCAAATCGGAG 
GTCCAATCACAATCGCATGC 
pnr 3R:11851381..11851900 23 TCTCTTGCTCTTTCGCTCAC 
GTTTTCCATACGCACTCACAC 
grn 3R:3977 421 .. 3977780 123 CACAGCTCGAAATGACAAACG 
TTCGCTGTCTCTTTCACTGG 
CG13896 3L:723581..723960 119 TCTCTGTCCCTCAAGCTATGG 
CTGTAGAAGTCCAGCTGTTCAG 
abd-A 3R:12637441..12638040 64 CCCATAAATCACGACTCCCAG 
TCGCTCAGATCCACATTCAC 
bab2 3L:1127161..1127580 57 TTGGCCTCGACTGTTGATG 
GGCAAAGAAAAGTTGGGTGG 
CG12484 2R: 16326581 .. 16327020 132 CCACTAGCCCATAACAGTAACAG 
TTCGGACTGGTCGTTTATGG 
zfu1 3R:26589841 .. 26590200 77 GGAAAATGGCTGGGAAAATGG 
TGGAAAATGTGAGAGCAGGAG 
CG4774 3R:21514901..21515540 28 CCTAGTGAAGATGGCTAACGTC 
GTATAGAGATGGCCGCTAATGG 
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B. Control Genes used in qPCR 
Gene Control Type ~nmers(top-forelfard) 
Hsp22 Negative TCTGCGTATGGAAACTGACC 
TTCTTTAGCGAACTCCGTGG 
Hsp26 Negative AATAGTGGGAGATTGCTGGC 
CCTTTCCCAATAAATGCCATGAG 
Pc Negative CTATTCCATTGTCCTGTTTGCG 
ACGTCAAAACTATGAGAGGCG 
bxd Positive CAAAACACGAATACAAGCCCG 
CTGTATCTCGCTCTTACGCAC 
iab2 Positive TCGCTCAGATCCACATTCAC 
CCCATAAATCACGACTCCCAG 
en_DM Positive GGAATGGGTAAGAGGAAGATGG 
AACTGGAAACTGGAACGGAG 
hth Ringrose ACCGCCATAATCTTGACAGAC 
GCGTTGCCATAAAACACTTAGG 
unc-4 Ringrose GGCTGATCGAAATTGAAACGG 
AGCGAGGAAACCCAGAAAAG 
ldgf4 Ringrose AAGGCGAGAGGGAGATAGAG 
ACATTTTCACCAGGACAGGG 
cato Ringrose CAAGTTTGTGTAAATGGCCCG 
AAATTATGGGCGACAGAGGG 
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Appendix Table 4.5. Genes present in at least 50% of CHIP experiments 
CBX2 SCNNlB SST TBX22 DPY19L2 DPYSLS CTNND2 
CGNLl C18orfl TMEM2 TMEM65 EMXl FRMPDl DHH 
GABRQ EPN3 TMEM26 ABO HOXD12 HOXC6 DLXl 
FHLl CPAMD8 EDN3 ALK HS3ST4 HOXDl EOMES 
PANX2 NPRl AVPRlA AVP IGFBPl HOXDll FBPl 
ADRA2B PDGFB C1QTNF4 BMPER NKX2-5 KCNK17 FOXD2 
CACNG7 RHCG CGREFl C1QL3 NPYSR NGB GABRA4 
CNFN ZNF232 FADS6 C1QTNF2 SLC17A7 NIN GDF6 
CUTL2 C14orf162 GOS2 CDKN2A SMPD3 NKXG-2 GDNF 
CYP19Al CBLN2 GPMGB CRH TBClDl NTRKl GHR 
DPCRl CHST2 GRIN2C CSPGS TCFlS OTOPl GPR120 
FAM70A DACTl LHXl DAPK2 THSD3 POU3Fl GPR88 
GPRCSA DIRAS2 LHX9 DDX25 HLA-G POU3F2 GRIK3 
HAPLN4 GFRA3 NDRG2 EPO CNNM2 SCUBE3 GSCL 
JPH3 GIPC3 PREXl FHL2 CNTNAPS SOXl HAND2 
LGR6 HOP RRAD GPC3 DFNAS SYTlO HBAl 
NTFS IGSFll SEZ6 HS3ST1 EPS8 TCF21 HHIP 
PRDM14 KALl SHD LYPDl GPR126 TFAP2D HTRlA 
PTPRO KCNIPl SLC6A4 MTlG HOXA6 TMEM46 I CAMS 
RARRES2 KLKl SSTR4 MYOlO KCNJlO CD38 INA 
RDH8 LGICZl FGFll NPTXR MLPH EGR2 ISLl 
RPL38 LPPR4 RASDl NR3C2 RUNX2 GFil ISL2 
SRPX LTF SEZGL NRXNl SLIT3 C2orf32 ITGA4 
TRPC4 NTSRl SLC13A3 PCDHlO TLE2 EPB41L4A KCNK12 
TUB P2RX2 WNTSA RNF157 FOXD4Ll FAM84A KCNQ3 
BMP7 PCDH7 CDYL SATB2 MLNR NFIX KCNVl 
CACNG4 PLCXD3 F13Al SLC04Al OVOLl ECELl KY 
CACNG8 PVALB GADD45G SNTBl RIPK3 LRRTMl LHX4 
CHAT RASGEFlA GRM2 TNFRSF13C CACNAlE PTHLH MSXl 
HCK RDHE2 NKPDl IRAK3 CBR3 BARHLl MYF6 
HOXClO RPRML OSBP2 NTN4 CD44 BCL2 NPR3 
OPCML RSP03 RPS6KA2 ADAMTSL3 CLEC4G CACNAlB NTRK2 
PTCHDl SEMASB SMOX CA7 cues CACNAlD OLFML2B 
RAI2 SNCB SOX9 CARTl COL12Al CNNMl OSRl 
GPR101 CITEDl HOXC4 MAP6 NR2El PMP22 SIX6 
GJB2 C20orf103 COLEC12 KIRREL3 SSTR2 ZBTB16 ROB03 
HOXB6 HOXC8 NEFH PLXNCl POMC TRPCS DUOX2 
NELLl NOL4 PGR PHOX2B PTGDR SLC32Al VDR 
SLC30A3 SLC02Al SLCOSAl TBXS TMEFF2 TRIM36 TSLP 
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OTXl LRRKl CACNA2D2 ACTL6B NOG CACNAlG TBRl 
PDGFRA RPP25 COL9Al FAM80A NRNl CD34 TCF2 
PENK ADAM23 CYGB FGF20 NXPH4 CD8A TIP39 
PRDM12 APCDDl FAM46C GPR158 PCDH17 CENTA2 TLX2 
PRKCE ATP8A2 FOXC2 GPR26 PRDM13 CIDEA WNT6 
RBP4 BDKRB2 HlFO IRF4 RAB40B CSMD3 ZADH2 
SFRPS BMX KCNS3 KCNJS RFXDCl CYP26Bl ZIC4 
SIX2 C14orf37 LIMS2 KCNK3 SEMA6D DCC CBX8 
SLC10A4 FGF17 LIPG MAPK81P2 ST8SIA1 DKFZP56400823 CH25H 
SLC1A4 GALNTLl NFATCl RAB9B TFAP2B DOK6 COL24Al 
SLC30A4 NMNAT2 PODXL2 RASGRPl VGLL2 EN2 FBN2 
SLC9A2 PAQRS PTPNS SORCS2 ZICl FAMSB KLF4 
SORCS3 PPP1R16B RAB6B EYA2 ADAMTSS FGF3 MLLT3 
SPOCK3 SLCSA8 SLC26A10 AQPS ALOXS FOXFl PLXNA2 
TFAP2E SLITRK2 ST6GALNAC2 GDA MESPl FOXJl RASSFS 
TLXl CDH22 STAC2 DPF3 MTlA GATA4 RGSlO 
TMOD2 CDH4 TSC22D3 EGFL6 NAGS GIMAPS STK32B 
TRADD GRIN2B ACCNl EPHAlO NFI A GRIDl ZNF503 
TRH NRXN3 ABCC3 EVXl PITX3 GUCY2D PTGFR 
WNT2 PRPH CDH13 FOXGlB PPP1R14C HPCAL4 SORCSl 
HEYl SOX3 ERG FOXLl SFRP4 HPSE2 TCEA3 
NAP1L2 FBXL16 GADl GABRA2 TRIM7 IRX4 soxs 
CCND2 PHOSPHOl HOXAlO GSHl ZNF365 KCNA3 ACCN4 
C15orf27 ABCGl HTR2C HLXl CHN2 KCNK2 ATP1B2 
DUSP9 DPP4 KCNJ9 HLXB9 EIF4E3 MAPT C20orf39 
FGF13 EPB49 NEFL HOXCll PHYHIPL NEURODl EPB41Ll 
NPAS3 FAM19A2 NOSl IGF2 SLC3SD3 NEUROGl FAM81A 
PNPLAS PLXDCl RNF128 KCNC4 LOC400120 NKX2-2 GAB3 
RORA AATF TRHDE KCNIP4 CXCL16 OCA2 GAL 
MSil ADAMll WNT3 KCNK4 HES7 PAX6 GNAS 
ABCC4 ADAMTS17 FOXAl MAL TBX2 SIXl KIRREL2 
ADRBK2 ADAMTS8 INHBB MSX2 ADCY8 SLC6A3 RGMA 
C13orf18 ADCYl LAMBl MTlH ADRB3 SPAG6 SHANKl 
CACNG3 BRUNOL4 MTSSl NGFR ALX4 STXBP6 SLC7A10 
ASCL2 DLX4 DMRTl HS3ST3Bl LHX6 RTN4RL2 SHH 
MAFB MYODl NRG2 OTOP3 PAX3 PROK2 SIX3 
GPR12 KCNAl LHXS WNTlOB NPASl ADCY4 ATOHl 
CNTFR EFNAl ITPKA SIDTl ALX3 CDH7 COL25Al 
ZFYVE28 RAB37 HBA2 RFX4 RGS6 ALOXlS VAX2 
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CCKBR OLIGl LYSMD2 CRTACl RYR3 KCNKlO FZDl 
KCNNl XYLTl PRKCH DGKG SLC30A2 DGKZ HAPl 
SPTB ClQLl TNFRSFllA DGKI SLCGAl ARHGAPG LPL 
KCNGl FBX03 GALR2 DMRT2 SLITl BCAN METRNL 
MNl GRINl HS3ST2 DSC3 SLITRK3 BDNF NRIP3 
ALDH1A2 HOXA7 KLK4 FAM43B SOX14 CHSTl PAXS 
C1QL2 LMODl MDSl FEV SOX7 CHST8 PDE8B 
CACNA2D3 MDGAl PAX9 FGF9 SSTRl FGF14 PSD2 
CNIH3 MTlB RBP7 FOXA2 TBX21 IL17RB REP 52 
COL23Al NEURL ADRA2A FOXL2 WNT3A SNIP ST8SIAS 
CRHR2 PTPRN2 BMPG FZDlO ABTB2 DLKl ABCC8 
GREMl RIM 54 COCH GATA2 EPHB3 SPONl ADCYAPl 
GRMl SPOCK2 COL27Al HOXD13 MSC pyy BHLHB3 
GRP SYTG CRHBP HS6ST3 CHRD ACCN2 CALCA 
H2AFY2 KCNAS DCHS2 KCND3 CLEC14A KCNJ4 CHRDL2 
NDRG4 CRMPl FERD3L LBXl EFNA3 NCAMl COL2Al 
NRXN2 CRYBA2 FOXQl NEUROD2 ERBB4 NPHS2 CRHRl 
NXPH2 FU33790 HSPAG NEUROG2 FLRT2 NRCAM DLL4 
PAPLN HLF IRXl NKX2-3 GALNTL4 DSCAMLl DMRT3 
PPPlRlB HOXB13 NKX3-1 NKX2-8 RGS20 ELAVL3 ELMODl 
SLC24A3 HOXB7 NRGl NKXG-1 SNFT HOXC12 GATAG 
ZCCHC12 HOXB8 PTGER3 NPTXl WNT7A IL1RAPL2 LGRS 
FOXBl HOXD3 SLC40Al ONECUTl Clorf92 SIMl NAV2 
GPRSO HOXD9 SPON2 OTP LTK SLC6A2 OLIG2 
HOXC9 KCNJG IRX3 OTX2 OPRDl SLCGA20 ONECUT2 
NTRK3 LGI3 ADAMTS15 PAX2 PODN SLC8A3 OTOP2 
PAXl LHFPL3 ARHGAP20 PCDH8 SHOX2 TLX3 PHOX2A 
PCSK2 MEOX2 CBLN4 PITX2 UCPl DUOXl POU4Fl 
SLC18A3 OLIG3 IRXS POU4F2 SYT3 ZMYND15 POU4F3 
CBX4 SV2B ADRAlA PRAC C21orf29 ARNTL SCN4B 
PDElB TBXl BARX2 PTFlA ARX PHLDBl 51M2 
PRKCBl TBX20 BNCl PTGER2 FXYDG PRICKLE! ST8SIA2 
CLICG CCNAl CAlO PTPRT LONRF3 ATF3 WNTl 
LAMA3 KCNQl CDKSR2 RAX RPH3A CACNB4 C21orf63 
SLC1A2 WTl ASCLl COMP CRLFl HRK PAX7 
SLC24A4 VSXl INSMl WNTll LRP2 KCNABl INSM2 
BARHL2 COL9A2 CXCL14 CYP26Al 0103 GPCS GRIKl 
DACHl EGR4 GHSR GRIN3A GSC MCOLN3 NTNG2 
ADAMTS18 MEGFll SLC27A2 USHlG ABCG4 CALCR CAMK2B 
SLITRKl STMN2 RASGRFl Flll HES2 KCNH3 KCNK13 
HOXB2 HOXB3 NR2F2 PAX8 PDE4DIP ASTN2 ATOH8 
CDH23 ENl EPHAS EPHBl FRMD3 GBX2 GRIA2 
TBX3 
TRIM9 
UCN 
CACNAlA 
CACNG2 
HOXB9 
MYHll 
TMEM16B 
C20orf46 
ATP1A3 
CA4 
CYP2Al3 
GJBG 
PHACTR3 
TBX4 
RIPK4 
WNTSB 
ARHGEF7 
HOXC13 
ITGAll 
UPBl 
EMX2 
HOXBl 
RXRG 
CYP24Al 
CDX2 
DLX3 
TAll 
INSRR 
KCNMAl 
Kl 
LHX2 
LMXlB 
NEUROG3 
NR4A3 
SCTR 
SGPP2 
SLC35F3 
SLIT2 
ADRBl 
BHLHBS 
GUCY1A3 
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Appendix Table 4.6. All enrichments within an Enrichment Category that meet a 
threshold of 1.5. Categories are a) Embryonic Stem Cells, b) Cancer Cells, 
c)Differentiated Cells, d) The 758 genes that are present in at least half of all the CHIP 
experiments, e) Low CpG content CpG islands, t) High CpG content CpG islands 
A. Embryonic Stem Cells 
#of 
promoters 
758 top758 
190 UCSC_CpG-3+ 
1325 UCSC_CpG-2+ 
1135 UCSC_CpG-2 
64 znf354chighcon 
1407 $LHX3_01 
1855 NRSF 
2012 NFKBl-highcon 
1936 7 gmd-highcon 
487 SMTITIGT 
2091 17md-con 
1826 motifl-highcon 
1795 17md-highcon 
2727 7gmd-con 
4194 NFKBl-con 
7476 cpg-1 
TFAP2A-6378 highcon 
1466 motif6-highcon 
5636 758m0highcon 
1317 $AP1_C 
3831 motifl-con 
5753 motif2-highcon 
3073 mat4-lcons 
Lymphoma-
1957 Top 10% 
Under-
ES ave. 
11.79 
4.19 
2.73 
2.49 
2.37 
2.23 
2.22 
2.16 
2.13 
2.10 
2.09 
2.08 
2.07 
2.04 
2.02 
2.00 
1.98 
1.97 
1.93 
1.93 
1.91 
1.90 
1.90 
1.88 
2083 
232 
2583 
1957 
3967 
7829 
860 
6217 
6199 
3918 
3660 
1094 
8209 
4514 
165 
9961 
138 
1809 
9095 
5030 
2389 
6519 
4167 
1530 
motif4-highcon 1.80 3961 cpg_edge-1-1 1.62 
znf354chigh 1.80 8530 nrfl-high 1.61 
$TATA_01 1.79 7566 MZF1-4-con 1.61 
Rectal Adenoma 1.78 5422 cpg_edge-3-2 1.60 
vs. Normal 
$SP1_Q6 1.77 2632 deltaefl high con 1.60 
10gm4highcon 1.76 3203 LHX3_cons-5 1.59 
Lung 
Adenocarcinoma 1.76 2700 LHX3-con 1.58 
vs. Normal 
10gm2-con 1.76 203 mat_Ocons 1.57 
Invasive Ductal 
10gm3-con 1.76 978 Breast Carcinoma 1.57 
vs. Normal 
Ductal Breast 
p300highcon 1.74 618 Carcinoma vs. 1.57 
Normal 
motif6-con 1.74 1414 14md-con 1.56 
Small Cell Lung 
Carcinoma vs. 1.74 246 GCGNNANTTCC 1.55 
Normal 
motif5-highcon 1.74 671 lcg3+-5 1.55 
nrfl-highcon 1.73 260 yyl-high 1.55 
NRSF 1.73 11029 Lcg_8 1.55 
HCG promoters 1.72 8695 17ggm4-con 1.54 
Squamous Cell 
yy 1-highcon 1.71 1262 Lung Carcinoma 1.54 
vs. Normal 
sef- 1.69 6059 motifl-high 1.53 l(cisgenome) 
pax4highcon 1.69 1368 SOX9-highcon 1.53 
mp_3-1 1.69 2230 exsrl-flil 1.53 
Colon 
tp53 1.69 925 Adenocarcinoma 1.52 
vs. Normal 
NFKBl-high 1.69 3413 ap l_c-highcon 1.52 
lcg3+ _gad_3 1.69 11175 nrfl 1.52 
Prostate 
Carcinoma vs. 1.68 6575 tlx 1-nfic 1.52 
Normal 
97 
expressed 
(Wooster 
CellLine) 
4285 MZFI-4- 1.87 5802 17 ggm4-highcon 1.68 7780 HMX3 1.52 highcon 
228 $NFKB_Q6_01 1.86 8512 motif2-con 1.68 4200 mp_7-0 1.51 
2875 motif3-highcon 1.86 9512 IOmd-con 1.68 1060 HENI (A) 1.51 
5600 10gmd3- 1.85 8711 sp 1-highcon 1.68 10963 motif2-high 1.50 highcon 
Colorectal 
Cancer- Top 
1957 10% Under- 1.85 1409 Egr-1 1.68 11373 motifS-con 1.50 
expressed 
(Wooster 
CellLine) 
Prostate 
858 Carcinoma vs. 1.85 451 $IRF_Q6 1.68 2384 lcg3+ _gad_8 1.50 
Normal 
Genes with at 
least one ERa 
5032 rest 1.84 1297 LHX3-highcon 1.66 1364 binding site within 1.50 20kb of 
transcriptional 
start site 
1572 $NFAT_Q4_01 1.84 3484 CREB 1-highcon 1.65 
6330 7 gmd2-highcon 1.82 6370 motif3-con 1.65 
Prostate 
6065 nrf1-con 1.81 1777 Adenocarcinoma 1.65 
vs. Normal 
4325 10gm3-highcon 1.81 4881 motif4-con 1.64 
4326 10gm2-highcon 1.81 2358 LHX3_cons-9 1.63 
7611 I Omd-highcon 1.81 9174 l0gmd3-con 1.62 
B. Cancer Cells 
Can 
# of promoters average 
758 top758 4.25 
190 UCSC_CpG-3+ 1.86 
3692 LCG promoters 1.77 
858 
Prostate Carcinoma vs. 1.76 
Normal 
136 SEF-1 1.72 
1407 $LHX3_01 1.60 
228 $NFKB_Q6_01 1.58 
1957 Rectal Adenoma vs. 1.54 
Normal 
165 NRSF 1.52 
1317 $AP1_C 1.52 
98 
1855 NRSF 1.51 
c. Developed Cells 
Dev 
# of promoters average 
758 top758 5.83 
190 UCSC_CpG-3+ 2.38 
64 znf354ch ighcon 1.92 
1325 UCSC_CpG-2+ 1.82 
1135 UCSC_CpG-2 1.73 
858 Prostate Carcinoma vs. 1.68 Normal 
1317 $AP1_C 1.64 
165 NRSF 1.63 
Lymphoma- Top 10% 
1957 Under-expressed 1.62 
(Wooster Cellline) 
7476 cpg-1 1.62 
860 Lung Adenocarcinoma vs. 1.61 Normal 
1407 $LHX3 01 1.58 
1855 NRSF 1.57 
2583 $TATA_01 1.53 
2012 NFKB1-highcon 1.51 
D. All Cell Average 
tot 
#of promoters average 
758 top758 6.95 
190 UCSC_CpG-3+ 2.81 
1325 UCSC_CpG-2+ 1.97 
64 znf354chighcon 1.85 
1135 UCSC_CpG-2 1.83 
1407 $LHX3_01 1.76 
858 Prostate Carcinoma vs. 1.75 Normal 
1855 NRSF 1.73 
1317 $AP1_C 1.68 
1936 7gmd-highcon 1.63 
99 
7476 cpg-1 1.63 
2012 NFKB1-highcon 1.63 
Lymphoma- Top 10% 
1957 Under-expressed 1.62 
(Wooster Cellline) 
2091 17md-con 1.62 
1795 17md-h ighcon 1.61 
487 SMTTTTGT 1.60 
1826 motif1-highcon 1.60 
860 Lung Adenocarcinoma vs. 1.58 Normal 
228 $NFKB_Q6_01 1.58 
2727 7gmd-con 1.57 
1957 Rectal Adenoma vs. 1.56 Normal 
2583 $TATA_01 1.56 
165 NRSF 1.55 
4194 NFKB1-con 1.54 
5636 758m0highcon 1.54 
1094 Small Cell Lung Carcinoma 1.52 
vs. Normal 
232 znf354chigh 1.52 
6378 TFAP2A-highcon 1.51 
1572 $NFAT_Q4_01 1.50 
1466 motif6-highcon 1.50 
E. 758 genes that were present in at least half of the experiments (* represents p-
value smaller than w-15) 
#of promoters Top p-val 758 
758 top758 28.09 6065 nrf1-con 2.02 * 
190 UCSC CpG-3+ 6.06 * 6199 10gm3-con 2.01 * 
1325 UCSC CpG-2+ 3.60 * 3073 mat4-1cons 2.00 * 
1135 UCSC CpG-2 3.19 * 6217 10gm2-con 2.00 * 
1407 $LHX3 01 2.70 * 2083 motif4-highcon 1.97 * 
231 17gmeme 2.68 1.96E-05 7611 10md-highcon 1.97 * 
Colo rectal 
Cancer-Top 
487 SMTTTTGT 2.65 1.31E-09 1957 10% Under- 1.95 1.76E-14 
expressed 
(Wooster 
100 
Cellline) 
1936 7gmd-highcon 2.63 * 2389 tp53 1.95 * 
2091 17md-con 2.57 * 3660 motif6-con 1.94 * 
1317 $AP1 C 2.56 * 4514 nrf1-highcon 1.94 * 
2012 NFKB1-highcon 2.55 * 8209 motif5-h ighcon 1.93 * 
1826 motif1-highcon 2.54 * 1572 $NFAT Q4 01 1.91 2.81E-11 
Prostate 
2727 7gmd-con 2.52 * 858 Carcinoma vs. 1.90 1.22E-06 
Normal 
1795 17md-highcon 2.52 * 1809 sef-1(cisgenome) 1.89 1.78E-12 
1855 NRSF 2.48 * 5802 17ggm4-highcon 1.89 * 
4194 NFKB1-con 2.36 * 3484 CREB1-h ighcon 1.89 * 
451 $1RF Q6 2.24 3.67E-06 3961 cpg edge-1-1 1.89 * 
138 yy1-highcon 2.24 6.59E-03 3918 p300highcon 1.87 * 
5636 758m0highcon 2.24 * 5030 mp 3-1 1.85 * 
228 $NFKB Q6 01 2.22 8.58E-04 6370 motif3-con 1.84 * 
64 znf354ch ighcon 2.19 5.13E-02 1297 LHX3-highcon 1.84 1.83E-08 
6378 TFAP2A- 2.18 * 8512 motif2-con 1.83 * highcon 
2875 motif3-h ighcon 2.17 * 2358 LHX3 cons-9 1.83 3.70E-14 
5753 motif2-highcon 2.15 * 6519 NFKB1-high 1.83 * 
3831 motifl-con 2.15 * 6519 nfkb1-high 1.83 * 
1466 motif6-highcon 2.11 3.19E-14 4881 motif4-con 1.82 * 
4325 10gm3-h ighcon 2.10 * 9095 pax4highcon 1.82 * 
4326 10gm2-highcon 2.10 * 8711 sp1-highcon 1.82 * 
3967 $SP1 Q6 2.10 * 8711 sp1-highcon 1.82 * 
5600 10gmd3- 2.10 * 1409 Egr-1 1.81 2.23E-08 highcon 
2583 $TATA 01 2.10 * 9512 10md-con 1.81 * 
5032 rest 2.07 * 1414 14md-con 1.81 1.32E-08 
Lung 
232 znf354chigh 2.06 5.09E-03 860 Adenocarcinoma 1.80 1.03E-05 
vs. Normal 
6330 7gmd2-highcon 2.04 * 9174 10gmd3-con 1.79 * 
4285 MZFl-4- 2.03 * 2632 deltaef1h ighcon 1.78 1.33E-14 highcon 
5422 cpg edge-3-2 1.78 * 10913 TFAP2A-high 1.57 * 
Breast Cancer-
Top 10% 
1262 Under- 1.78 3.48E-07 717 14md-highcon 1.57 2.44E-03 
expressed 
(Shankavaram 
101 
Cell line) 
4167 lcg3+ gad 3 1.77 * 12262 sp1-con 1.57 * 
3203 lHX3 cons-5 1.76 * 12262 sp1-con 1.57 * 
Small Cell lung 
7566 MZF1-4-con 1.76 * 1094 Carcinoma vs. 1.57 1.50E-04 
Normal 
2700 lHX3-con 1.73 4.83E-13 12586 10md-high 1.56 * 
1368 SOX9-highcon 1.72 3.26E-07 3413 ap1 c-highcon 1.56 2.30E-11 
8530 nrf1-high 1.71 * 1725 osf2-highcon 1.56 3.14E-06 
10514 HCG promoters 1.71 * 12123 mat4-2cons 1.55 * 
8695 17ggm4-con 1.70 * 10963 motif2-high 1.55 * 
Rectal 
1957 Adenoma vs. 1.69 3.54E-09 671 lcg3+-5 1.55 2.46E-03 
Normal 
6059 motif1-h igh 1.68 * 8626 7gmd-high 1.54 * 
4200 mp 7-0 1.67 * 7707 motif4-high 1.54 * 
1513 Pax-9 1.67 4.70E-07 11790 nfkb1 1.53 * 
1060 HEN1 (A) 1.67 3.91E-05 10116 ElK1-con 1.53 * 
2230 exsr1-fli1 1.65 2.19E-09 165 NRSF 1.53 6.43E-02 
lymphoma-
Top 10% 
1957 Under- 1.64 4.06E-08 6503 znf354ccon 1.53 * expressed 
(Wooster 
Cell line) 
6058 ElK1-highcon 1.63 * 1328 $YY1 Q6 1.52 9.76E-05 
Invasive Ductal 
3188 lHX3-3 1.62 2.49E-12 978 Breast 1.52 6.47E-04 Carcinoma vs. 
Normal 
260 yy1-high 1.62 2.18E-02 203 mat Ocons 1.52 5.06E-02 
Prostate Colon 
1530 Carcinoma vs. 1.62 2.32E-06 925 Adenocarcinoma 1.52 9.11E-04 
Normal vs. Normal 
7780 HMX3 1.61 * 1148 AR (A) 1.52 2.89E-04 
Prostate 
11373 motifS-con 1.61 * 1777 Adenocarcinoma 1.50 1.59E-05 
vs. Normal 
11029 leg 8 1.61 * 7445 ap1 c-con 1.50 * 
5213 motif6-high 1.61 * 8870 motif3-high 1.50 * 
8461 p300con 1.60 * 
6575 tlx1-nfic 1.60 * 
102 
246 GCGNNANTTCC 1.60 2.71E-02 
7449 CREB1-con 1.60 * 
2384 lcg3+ gad 8 1.59 1.12E-08 
4123 osf2-con 1.58 1.55E-14 
11175 nrf1 1.58 * 
11062 7gmd2-con 1.57 * 
6055 rxra-vdr 1.57 * 
12095 TFAP2A-con 1.57 * 
F. Low CpG content CpG Islands(* represents p-value smaller than 10-15) 
# of promoters LCG p-val 
3891 LCG promoters 5.77 
136 SEF-1 2.12 1.62E-07 
1404 Pit-1 2.12 * 
1462 PEBP 2.08 * 
1420 Osf2 2.01 * 
2583 $TATA_01 1.96 * 
68 Brachyury 1.95 9.47E-04 
1071 Lhx3{transf) 1.93 * 
1446 AML 1.92 * 
1139 core-binding 1.92 * factor 
1404 IRF {A) 1.92 * 
542 $ETS2_B 1.82 1.66E-14 
1957 Rectal Adenoma 1.82 * vs. Normal 
1407 $LHX3_01 1.81 * 
1270 CHX10 1.78 * 
1478 LEF1TCF1 1.78 * 
Colon 
925 Adenocarcinoma 1.76 * 
vs. Normal 
1481 Lmo2 complex 1.71 * 
1317 $AP1_C 1.66 * 
228 $NFKB_Q6_01 1.62 7.98E-05 
1449 IRF-7 1.58 * 
451 $1RF _Q6 1.57 9.44E-07 
Lung 
860 Adenocarcinoma 1.56 6.21E-11 
vs. Normal 
1094 Small Cell Lung 1.54 2.68E-13 
Carcinoma vs. 
Normal 
Squamous Cell 
1262 Lung Carcinoma 
vs. Normal 
1.51 1.41E-13 
G. High CpG content CpG Islands(* represents p-value smaller than 10-15) 
10514 HCG 2.03 promoters 
758 top758 1.71 * 
1250 Nrf-1 1.59 * 
1409 Egr-1 1.56 * 
886 CREB {a) 1.52 * 
1414 DEAF1 {A) 1.52 * 
1288 ATF {A) 1.51 * 
3967 $SP1_Q6 1.50 * 
103 
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Appendix Table 4.7. All motifs used in analysis and their origin 
#of Program 
promoters Motifs Type used 
3073 mat4-1cons Computational CisGenome 
3961 cpg_edge-1-1 Computational CisGenome 
203 mat_Ocons Computational CisGenome 
671 lcg3+-5 Computational CisGenome 
5422 cpg_edge-3-2 Computational CisGenome 
11029 Lcg_8 Computational CisGenome 
13791 lcg3+-4 Computational CisGenome 
14758 Lcg_S Computational CisGenome 
12305 lcg3+-2 Computational CisGenome 
8071 cpg_edge-2-1 Computational CisGenome 
15199 Lcg_2 Computational·· CisGenome 
9424 Lcg_3 Computational CisGenome 
9531 lcg3+-9 Computational CisGenome 
10124 lcg3+-1 Computational CisGenome 
12903 Lcg_7 Computational CisGenome 
12144 758m3 Computational CisGenome 
11702 lcg3+-6 Computational CisGenome 
9405 lcg3+-0 Computational CisGenome 
1011 cpg_edge_3-1 Computational CisGenome 
12728 lcg3+-8-2 Computational CisGenome 
7847 lcg3+-8 Computational CisGenome 
7419 Lcg_1 Computational CisGenome 
5030 mp_3-1 Derived Motif CisGenome 
4200 mp_7-0 Derived Motif CisGenome 
11510 MP_1-1 Derived Motif CisGenome 
10355 mp_6-0 Derived Motif CisGenome 
8367 mp_4-0 Derived Motif CisGenome 
14463 mp_2-1 Derived Motif CisGenome 
14532 mp_S-0 Derived Motif CisGenome 
5032 rest JASPAR CisGenome 
2230 exsr1-fli1 JASPAR CisGenome 
6575 tlx1-nfic JASPAR CisGenome 
11175 nrf1 JASPAR CisGenome 
11790 nfkb1 JASPAR CisGenome 
6055 rxra-vdr JASPAR CisGenome 
11662 e2f1 JASPAR CisGenome 
13099 nfkb JASPAR CisGenome 
14916 nhlh1 JASPAR CisGenome 
12680 rei a JASPAR CisGenome 
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13464 mizf JASPAR CisGenome 
12530 myc-max JASPAR CisGenome 
15113 myf JASPAR CisGenome 
8517 CREB JASPAR CisGenome 
4277 srf JASPAR CisGenome 
12314 myb JASPAR CisGenome 
13388 brca1 JASPAR CisGenome 
12307 nr3c1 JASPAR CisGenome 
13259 nfe212 JASPAR CisGenome 
13158 nr2fl JASPAR CisGenome 
15990 rei JASPAR CisGenome 
14537 nfya JASPAR CisGenome 
10693 gata2 JASPAR CisGenome 
8152 rora2 JASPAR CisGenome 
16367 creb1 JASPAR CisGenome 
15854 foxc1 JASPAR CisGenome 
12898 irf1 JASPAR CisGenome 
18300 tfap2a JASPAR CisGenome 
14721 nfatc2 JASPAR CisGenome 
17996 zeste JASPAR CisGenome 
15011 yy1 JASPAR CisGenome 
19191 10gmd3 JASPAR CisGenome 
14700 rora1 JASPAR CisGenome 
11499 pbx1 JASPAR CisGenome 
17925 elk1 JASPAR CisGenome 
13381 hlf JASPAR CisGenome 
15307 gata3 JASPAR CisGenome 
19332 sp1 JASPAR CisGenome 
16539 foxo3 JASPAR CisGenome 
17747 ap1 JASPAR CisGenome 
15790 sox9 JASPAR CisGenome 
15235 foxa1 JASPAR CisGenome 
13327 foxf2 JASPAR CisGenome 
16096 sry JASPAR CisGenome 
14636 nkx3-1 JASPAR CisGenome 
10370 nfil3 JASPAR CisGenome 
8354 foxl1 JASPAR CisGenome 
1754 nr1h2-rxra JASPAR CisGenome 
2358 LHX3_cons-9 non-PWM CisGenome 
3203 LHX3_cons-5 non-PWM CisGenome 
3188 LHX3-3 non-PWM CisGenome 
13379 mot_0-2_cons non-PWM CisGenome 
9014 zeste_cons non-PWM CisGenome 
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351 myb_cons non-PWM CisGenome 
10921 LHX3_cons-8 non-PWM CisGenome 
7862 LHX3_cons-2 non-PWM CisGenome 
5667 LHX3-2 non-PWM CisGenome 
10390 LHX3-1 non-PWM CisGenome 
1855 NRSF Transfac CisGenome 
1809 sef-1( cisgenome) Transfac CisGenome 
2389 tp53 Transfac CisGenome 
7780 HMX3 Transfac CisGenome 
8461 p300 Transfac CisGenome 
6503 znf354c Transfac CisGenome 
8757 deltaef1 Transfac CisGenome 
10901 pax6 Transfac CisGenome 
14519 osf2 Transfac CisGenome 
12734 LM02 Transfac CisGenome 
5893 CTCF Transfac CisGenome 
13177 elk4 Transfac CisGenome 
7028 oct1 Transfac CisGenome 
3994 gklf Transfac CisGenome 
16363 CREB1 Transfac CisGenome 
17337 ap1_c Transfac CisGenome 
4167 lcg3+ _gad_3 Computational GAD EM 
2384 lcg3+_gad_8 Computational GAD EM 
12521 lcg3+_gad_6 Computational GADEM 
12191 lcg3+ _gad_1 Computational GAD EM 
11299 lcg3+ _gad_7 computational GADEM 
1896 lcg3+ _gad_S Computational GAD EM 
11343 motif1 Computational GADEM 
14911 motif2 Computational GAD EM 
12826 ctrl2 Computational GADEM 
11908 ctrl1 Computationa I GAD EM 
14927 ctrl3 Computational GAD EM 
11127 motif6 Computational GAD EM 
14585 motif4 Computational GAD EM 
16645 10gm3 Computational GAD EM 
16659 10gm2 Computational GAD EM 
16712 lcg_withcpg_gad_3 Computational GAD EM 
15547 motif3 Computational GAD EM 
17678 17ggm4 Computational GAD EM 
18334 motifS computational GAD EM 
19535 lcg3+ _gad_ 4 Computational GAD EM 
9380 17md Computational Mdscan 
10715 7gmd Computational Mdscan 
107 
14775 lOmd Computational Mdscan 
6557 14md Computational Mdscan 
19793 7gmd2 Computational Mdscan 
18595 1gmd2 Computational Mdscan 
18894 1gmd Computational Mdscan 
1086 17gmeme Computational MEME 
487 SMTTTTGT motif derived Oncomine 
246 GCGNNANTICC motif derived Oncomine 
1407 $LHX3_01 Transfac Oncomine 
1317 $AP1_C Transfac Oncomine 
228 $NFKB_Q6_01 Transfac Oncomine 
2583 $TATA_01 Transfac Oncomine 
165 NRSF Transfac Oncomine 
1572 $NFAT_Q4_01 Transfac Oncomine 
3967 $SP1_Q6 Transfac Oncomine 
451 $1RF Q6 Transfac Oncomine 
136 SEF-1 Transfac Oncomine 
1409 Egr-1 Transfac Oncomine 
1513 Pax-9 Transfac Oncomine 
1060 HEN1 (A) Transfac Oncomine 
1530 MyoD Transfac Oncomine 
1434 Hmx3 Transfac Oncomine 
542 $ETS2_B Transfac Oncomine 
1148 AR (A) Transfac Oncomine 
1478 LEF1TCF1 Transfac Oncomine 
1193 NF-kappaB (A) Transfac Oncomine 
1292 NF-kappaB (C) Transfac Oncomine 
1452 c-Rel Transfac Oncomine 
1492 NF-kappaB (p65) Transfac Oncomine 
1328 $YY1_Q6 Transfac Oncomine 
1381 NF-kappaB (D) Transfac Oncomine 
1462 PEBP Transfac Oncomine 
1446 AML Transfac Oncomine 
1449 IRF-7 Transfac Oncomine 
1139 core-binding factor Transfac Oncomine 
1420 Osf2 Transfac Oncomine 
68 Brachyury Transfac Oncomine 
1481 Lmo2 complex Transfac Oncomine 
1270 CHX10 Transfac Oncomine 
1294 N-Myc Transfac Oncomine 
1404 IRF (A) Transfac Oncomine 
1071 Lhx3(transf) Transfac Oncomine 
1414 DEAF1 (A) Transfac Oncomine 
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1404 Pit-1 Transfac Oncomine 
1288 ATF (A) Transfac Oncomine 
886 CREB (a) Transfac Oncomine 
1250 Nrf-1 Transfac Oncomine 
Genes with at least one ERa 
1364 binding site within 20kb of Transfac Oncomine 
transcriptional start site 
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